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ABSTRACT 
 
 Diagnosing and managing heart failure (HF) can be challenging as patients sometimes 
present atypically with non-specific signs and symptoms. Effective management hinges upon an 
accurate, timely diagnosis.   
            An important component of physical examination, the assessment of jugular venous 
pressure (JVP), can assist in the diagnosis and management of HF. Clinical assessment of JVP 
can be performed at the bedside using the Lewis method whereby the height of the jugular 
venous pulse above the right atrium is measured. Reliability of the maneuver can be affected by 
variability related to the appropriate vein to use, reference points, and variable classification of 
normal versus abnormal.  A non-invasive point of care device, the Mespere Venous 1000 Central 
Venous Pressure (CVP) System, can be used to measure JVP. It has been approved by Health 
Canada and the Food and Drug Agency for commercial use.  
           The overall aim of this study was to conduct a preliminary evaluation of the feasibility of 
using the Mespere Venous 1000 CVP System to measure JVP for the diagnosis and management 
of HF in primary care and long term care (LTC). The study involved two projects: Project i and 
Project ii. Project i was conducted in one primary care and four LTC settings. It sought to gather 
qualitative information from the physicians and nurses about their perceptions relating to: 
measurement of JVP, acceptability of the device, perceived ease of use, and perceived barriers of 
the device. Focus groups and interviews were conducted with six physicians and nine nurses in 
primary care, and four physicians and ten nurses in LTC. Findings showed that the device was 
more acceptable and feasible to use for LTC clinicians than it was for primary care clinicians, 
particularly if its reliability among LTC residents could be demonstrated. Project i revealed that 
the low acceptability of the device in primary care appears to stem in part from a lack of 
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understanding of the importance of the JVP and patterns of practice that favor transfers of 
patients to emergency department (ED) for more definitive management. Project ii of the study 
aimed to assess the reliability of the device in the LTC setting. Two LTC physicians, two nurses 
and thirty six LTC residents participated in the study. The findings showed that the reliability of 
the device, when used by LTC nurses, was greater than that of physicians’ measures obtained 
with the Lewis method. 
 In conclusion, the study suggests that the use of the point of care (POC) Mespere Venous 
CVP 1000 System to measure JVP is acceptable and feasible in the LTC setting, but less so in 
primary care. In LTC, it provides more reliable measures of the JVP than does clinical 
assessment by physicians. Additional study is required to further improve the reliability of the 
device when used by LTC nurses. Further work is also required to develop primary care 
processes that promote HF management within primary care settings, and whether the device 
could have a role in such settings. 
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CHAPTER 1 
 
INTRODUCTION 
 
 HF is often misdiagnosed or undetected in primary care and LTC, thus preventing 
optimal management. The prevalence of HF cases is increasing with population aging. 
Improving the diagnosis of HF, thus facilitating more optimal management, is essential to curb 
its significant impact on patients and on health care resources.  
The assessment of JVP is an important measure recommended in guidelines to diagnose 
and manage HF. The measure is underutilized and devalued among modern clinicians. In 
addition to the conflicting recommendations as to how the measure should be obtained, there is a 
paucity of experimental literature investigating utility and perceptions of the clinical sign in 
primary care and LTC. The Mespere Venous CVP 1000 System is a non-invasive, POC device 
which measures JVP. Its role in primary care and LTC to supplement the diagnostic process for 
HF has not been evaluated. The overall focus of this study was to explore the potential of the 
device in these settings. The investigation adopted two projects – Project i and Project ii.       
1.1 Overview   
 
HF is defined as a complex clinical syndrome that arises secondary to abnormalities of 
cardiac structure and/or function (inherited or acquired) that impair the ability of the left 
ventricle to fill or eject blood at a rate commensurate to meet the metabolic needs of the body 
(Libby, Bonow, Mann & Zipes, 2008). More than 600,000 Canadians live with HF and 
approximately 50,000 new patients are diagnosed each year (Blais et al., 2014; Ross et al., 2006). 
Its prevalence is expected to increase over the next decades due to population aging (Curtis et al., 
2008) coupled with recent improvements in the survival rates of patients with coronary artery 
disease, a main risk factor for HF (McCullough et al., 2002). Although HF affects 1 to 2% of 
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Canadians (Chow, Donovan, Manuel, Johansen & Tu, 2005), it is predominantly a condition of 
the elderly with an incidence of 9.7% in those aged 75-84 and 17.4% in those aged 85 years and 
over (Bleumink et al., 2004). One in five individuals who survive to age 80 will develop HF over 
the remaining years of their life (Lloyd-Jones et al., 2002).  
 HF has been referred to as Canada's silent epidemic as it is associated with a prognosis 
that is markedly worse than other cardiovascular diseases. The condition has a devastating 
impact on an individual's quality of life by causing shortness of breath, fatigue, disability, and 
cognitive impairment. It is the second most responsible cause for hospitalization in those over 
the age of 65. These patients experience lengthy stays with up to 21% readmitted within 30 days 
(CIHI, 2012). Even though HF is largely an incurable condition, there are therapies that can help 
patients maximize their quality of life. Dietary modifications and pharmaceuticals coupled with 
weight loss and physical activity can alleviate symptoms. Thus,  part of the solution to improve 
the prognosis of the condition lies in earlier, more accurate diagnosis, and effective management.  
 Diagnosing and managing HF can be a process wrought with challenges, particularly 
among geriatric populations.  Symptoms may be subtle and when present, mistakenly attributed 
to senescence. Patients may not report symptoms until their condition becomes more severe. 
Atypical presentation is common in frail older adults who may present with geriatric syndromes 
such as functional decline or delirium. Other signs and symptoms can also occur in the setting of 
other conditions, such as Chronic Obstructive Pulmonary Disease (COPD). Amidst these 
challenges, one of the more useful clinical maneuvers for diagnosis and management of HF is the 
assessment of JVP.  
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 JVP is a specific sign of HF, and can be assessed through the Lewis Method which 
requires measurement of the venous pulse at the patient's bedside.  The Lewis Method entails the 
external measurement of the maximal height of jugular venous distension above the sternal angle 
while the patient is positioned at forty five degrees. JVP is reflective of intra-atrial pressure and 
volume fluid status. An elevated JVP is indicative of abnormal heart dynamics, usually implying 
fluid overload and the need for diuresis. Although not independently diagnostic, elevated levels 
are an important clinical finding as evidenced by its noteworthy value in many best practice 
guidelines (Maestre et al., 2009 ; Yancy et al., 2013). 
Despite the potential role of JVP measurement as a component in the diagnosis and 
management of HF, it is often underutilized, and many erroneously perceive the JVP as not 
helpful. Primary care and LTC clinicians have cited a high degree of uncertainty in their clinical 
skills which translates to indecision in establishing a diagnosis of HF and reliance on imaging 
(Heckman et al., 2014). Many practitioners of varying levels of seniority and experience do not 
measure JVP correctly, leading to a cycle of unreliable information, lack of confidence, and 
underuse of this sign (Chiaco, Parikh and Fergusson, 2013).  
In order to improve the reliability of the JVP measure at the POC, the non-invasive, 
Mespere Venous 1000 CVP System was developed for use at the bedside, and provides 
clinicians with a JVP measurement and its corresponding waveform. While the device has been 
approved by Health Canada for commercial use, its use in primary care and LTC settings has not 
been evaluated.   
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1.2 Research Objectives  
 
The overall objective of this study was to assess the acceptability and feasibility of using 
the Mespere Venous 1000 CVP System in the diagnosis and management of HF in primary care 
and in LTC settings.   
           Specific objectives of Project i include: 
i. Explore primary care and LTC clinicians’ perceived understanding of the JVP; 
ii. Describe the acceptability of the Mespere Venous 1000 CVP System to primary care 
and LTC clinicians; 
iii. Assess perceptions of the ease of use  of the Mespere Venous 1000 CVP System among 
clinicians in primary care and LTC; and 
iv. Identify perceived barriers to implementation of the Mespere Venous CVP System to 
measure JVP in primary care and LTC. 
     Specific objectives of Project ii include: 
v. Determine the inter-rater reliability of the Mespere Venous 1000  CVP System when 
used by LTC nurses; and 
vi. Determine the inter-rater reliability of the Lewis method to measure JVP when applied 
by physicians in LTC. 
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CHAPTER 2 
 
REVIEW OF LITERATURE 
 
 The intent of this study was to investigate the potential of a non-invasive, POC device to 
measure JVP in primary care and LTC. This chapter covers the following topics:  
(i) Definitions of Terms  
(ii) Pathophysiology of HF and JVP 
(iii) Prognosis and Management of HF 
(iv) Diagnostic Inaccuracy and Challenges  
(v) Significance of Symptoms and Signs  
(vi) Importance of JVP  
(vii) Clinical Assessment of JVP  
(viii) POC Devices and the Mespere 1000 CVP System 
2.1 Definition of Terms 
 Terms commonly used in this study are defined below.  
Central Venous Pressure: Measure of the filling pressure of the right ventricle and gives an 
estimate of the intravascular volume status. It is influenced by circulating blood volume, venous 
tone, and right ventricular function (Muralidhar, 2002).  
Chronic Disease: Non-communicable diseases that are of long duration and generally slow 
progression. The four main types are cardiovascular diseases (such as heart failure), cancers, 
chronic respiratory diseases (such as chronic obstructed pulmonary disease and asthma) and 
diabetes (World Health Organization, 2015). 
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HF: A complex clinical syndrome that arises secondary to abnormalities of cardiac structure 
and/or function (inherited or acquired) that impair the ability of the left ventricle to fill or eject 
blood at a commensurate rate to meet the metabolic needs of the body (Libby, Bonow, Mann & 
Zipes, 2008). 
JVP: The pressure within the jugular veins (Mann, 2011). 
LTC homes: Facilities which provide living accommodation for people who require on-site 
delivery of 24 hour, 7 days a week supervised care, including professional health services, 
personal care, and services such as meals, laundry and housekeeping (Healthycanadians.gc.ca, 
2004). 
Nurse Practitioner (NP): A RN with advanced university education provides personalized, 
quality health care to patients. A RN can specialize in one of four areas including primary health 
care, adult and pediatric care, and anesthesia (RNAO.ca, 2015). 
POC: Medical testing at or near the site of patient care (Kost, 1995). 
Primary Care: Day-to-day healthcare given by a health care provider. Typically this provider 
acts as the first contact and principal point of continuing care for patients within a healthcare 
system, and coordinates other specialist care that the patient may need. Patients commonly 
receive primary care from professionals such as a primary care physician (general 
practitioner or family physician), a nurse practitioner or a registered nurse. Depending on the 
nature of the health condition, patients may then be referred for secondary or tertiary care 
(Hawk, 2002). 
Registered Nurse (RN): A RN studies for a longer period of time, allowing for greater depth 
and breadth of foundational knowledge in the areas of clinical practice, decision-making, critical 
thinking, leadership, research utilization, and resource management (RNAO.ca, 2015). 
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Registered Practical Nurse (RPN): A RPN is a professional nurse. The autonomy of the RPN is 
influenced by the complexity of the client’s condition.  A RPN has greater autonomy when 
caring for a client with less-complex conditions. As client complexity increases, there is a 
corresponding increase in the need for a RPN to consult with RNs. RPNs work in clinical 
settings such as primary care and LTC (RNAO.ca, 2015).  
Specialists: Medical specialists are physicians who have completed advanced education and 
clinical training in a specific area of medicine such as cardiology and geriatrics (De Jong, 
Heiligers, Groenewegen & Hingstman, 2006). 
2.2 Pathophysiology of HF and JVP   
 The physiologic underpinnings of HF serve to understand the trajectory of the condition, 
diagnostic challenges, and need for effective management. The body's compensatory responses 
to HF lead to an elevation of JVP.     
 HF results from an initial injury affecting the cardiac muscle and subsequent systemic 
response. The reduced cardiac output and ensuing lack of adequate oxygen delivery begins as the 
consequence of any abnormality in cardiac structure or function. Depressed cardiac output arises 
as a result of systolic or diastolic left ventricular dysfunction, or a combination of both 
(Figuerora & Peters, 2006). Systolic dysfunction is commonly present in HF with Reduced 
Ejection Fraction (HF-REF) while diastolic dysfunction can occur in either HF-REF or HF with 
Preserved Ejection Fraction (HF-PEF). HF-REF is classified as a left ventricular ejection fraction 
less than 50% (Figuerora & Peters, 2006). On the other hand, HF-PEF is defined as left 
ventricular ejection fraction ≥50%) and its causes are similar to that of HF-REF with the most 
common being hypertension and ischemic heart disease (Figuerora & Peters, 2006).  
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 The physiologic responses to low cardiac output act to maintain mean arterial pressure 
(MAP) through activation of the Frank Starling mechanism, neurohormonal cascades and 
ventricular remodeling. In this way, the circulatory system is able to increase stroke volume, a 
variable determined by contractility of the cardiac muscle, preload and afterload. Preload is 
defined as the amount of myocardial fiber stretch at the end of diastole while afterload is the 
pressure the left ventricle must overcome to expel blood. The right atrial pressure reflects the 
preload of the right ventricle and is represented in the jugular veins. Thus, right atrial pressure 
can be assessed indirectly by measuring the JVP (Mann, 2011). The normal mean jugular venous 
pressure is 4 to 8 cm of water (or blood) or 3 to 6 mmHg (Mann, 2011). 
 Neurohormonal activation begins with the release of epinephrine and norepinephrine 
which increases heart rate and contractility. These catecholamines allow for vasoconstriction, in 
turn, elevating MAP towards its normal physiologic level. Furthermore, they initiate the  
renin-angiotensin-aldosterone cascade. Renin is an enzyme that cleaves angiotensinogen to 
angiotensin I in the liver and circulates in the bloodstream until it is spliced by angiotensin 
converting enzyme (ACE) to its active form, angiotensin II. This hormone signals the release of 
aldosterone from the adrenal cortex which triggers the release of norepinephrine and vasopressin. 
The response will increase preload and JVP, initially providing the peripheral tissue with 
sufficient oxygen and explains the stabilization phase observed in the progression of HF. Over 
time, the response is maladaptive as prolonged activation leads to myocardial toxicity and 
eventual reduction in ejection fraction, tachycardia, arrhythmias and myocyte loss (Chaggar, 
Malkin, Shaw, Williams & Channer, 2009). The neurohormonal mechanism can be found in 
APPENDIX i.  
 
9 
 
 Venous compliance and volume in the jugular veins are dynamic measures which are 
influenced by a number of variables. Alteration of venous volume can stem from decreased 
cardiac output, increased blood volume, changing from the standing to supine position, arterial 
dilation, and contraction of skeletal muscle (particularly legs and abdomen). Alternatively, 
changes in compliance can result from venous constriction, forced expiration and muscle 
contraction. Venous constriction can be caused by circulating vasoconstrictor substances such as 
catecholamines which decrease compliance and increase JVP. During a forced expiration, 
external compression of the vena cava functionally reduces the compliance of the vein, in turn 
increasing JVP (Mann, 2011). Muscular contractions, particularly of the abdomen and limbs lead 
to compression of the veins, decreases compliance, and forces blood into the thoracic 
compartment, thus increasing intrathoracic blood volume and JVP. 
 The mechanisms activated in HF are intended to maintain homeostasis in threatening 
situations such as intense exercise or hemorrhage, when MAP and output are affected. In these 
circumstances, these pathways are successful in negating the effects of hemodynamic 
abnormalities and as they are part of numerous negative feedback loops, the response is 
eventually quelled. However, in HF, the response never turns off as these systems are constantly 
attempting to compensate for the heart’s inability to maintain adequate output. The constantly 
circulating hormones exacerbate the hemodynamic problems in HF and promote further hormone 
release. As a result, intravascular volume and JVP will continually rise as HF progresses until a 
critical reduction in left ventricular ejection fraction is reached. At this point, the body will 
maximize its vasoconstrictive abilities to redirect blood to all vital organs. This will add to the 
hemodynamic burden and will incur rapid decline ending in terminal HF (Kemp & Conte, 2012).    
 
10 
 
2.3 Prognosis and Management of HF  
 HF is a chronic progressive condition with an unpredictable trajectory that varies widely 
between patients (FIGURE 1). The insults to the heart and systemic response cause a prolonged 
deterioration. Patients experience cycles of acute decompensation often requiring hospitalization 
and recovery. These cycles arise repeatedly before death which in 30% to 40% of HF patients 
occurs suddenly, while others occur from the progressive HF or associated comorbidities 
(Kannel & Belanger, 1991). HF incurs a significant overall burden on the health care system. 
FIGURE 1 - HEART FAILURE TRAJECTORY 
 
 
 
 
 
 
 
 
Source: Goodlin, 2009 
 Mortality 
 Despite advances in medical therapies and management, HF remains a highly lethal 
condition. The Framingham Heart Study followed patients between 1990 and 1999, finding that 
the risk of mortality significantly increased following a diagnosis of HF with 30 day, one year, 
and five year mortality rates being 10%, 20%-30% and 45%-65% respectively (Levy et al., 
2002). The five year rate for HF is the highest adjusted mortality rate when compared to 
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myocardial infarction and cancers of the bowel, prostate, ovary and bladder (Stewart et al., 
2001).  
Hospitalization 
 HF is the most common cause of hospital admission for those aged sixty five and older 
(Defrances, Lucas, Buie & Golosinskiy, 2008). More than 33,000 Canadians (Dai et al., 2012) 
and 1 million Americans (Butler, Marti, Pina & DeFilippi, 2012) are hospitalized every year with 
a primary diagnosis of HF. These patients spend an annual average of 26.9 days in hospital 
(Johansen, Strauss, Arnold, Moe & Liu, 2003). Approximately 25% of patients are readmitted 
within 30 days (Krumholz et al., 2009; Jencks, Williams & Coleman, 2009) and 50% within one 
year (Johansen, Strauss, Arnold, Moe & Liu, 2003). Recurrent HF and related cardiovascular 
etiologies are the primary cause for half of these readmissions while the other half are due to 
 comorbidities (Setoguchi & Stevenson, 2009).    
 Inconsistent findings have cited either an increase or decrease in the temporal trend of HF 
hospitalizations. The American National Hospital Discharge Summary found a 79% increase 
between 1979 and 2004 with HF as a primary diagnosis and a twofold increase when 
HF was listed as a discharge condition (Fang et al., 2004). Alternatively, another large scale 
study in the United States found a relative decline of 29.5% between 1998 and 2008 (Chen, 
Normand, Wang & Krumholz, 2011). Notwithstanding, adverse post discharge outcomes have 
remained relatively unchanged over the past two decades despite improvements in therapy (Blair 
et al., 2011) and policy developments in the USA to penalize 30-day HF related re-
hospitalization (The Patient Protection and Affordable Care Act, 2010).   
 Unnecessary hospitalizations are detrimental for older adults with HF as they lead to an 
elevated risk of death (Solomon et al., 2008). The CHARM trials recruited 7,572 chronic HF 
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patients who had nonfatal hospital visits with either preserved or reduced left ventricular ejection 
fraction. It was found that the mortality rate increased after hospitalization even when adjusting 
for baseline death predictors and was highest within the first month post discharge. The length of 
HF hospitalization and frequency were directly related to risk (Solomon et al., 2007). Significant 
predictors of acute HF decompensation and high readmission rates included patients’ poor 
compliance with therapy and diet restrictions, as well as failure to recognize early symptoms of 
HF deterioration (Malik et al., 2011). Following an acute episode of HF requiring 
hospitalization, estimated six month mortality rates range from 8% to 12% (Parikh, Felker & 
Metra, 2015). Hospitalization also leads to functional decline. One study found that almost one 
fourth of older adults with a mean age of 84 years and hospitalized for HF was discharged to 
LTC (Allen et al., 2011). Other estimates ranged from 13% to 18% (Jung, Yeh & Pressler, 2012).  
Hospitalization and Mortality in LTC  
  Most LTC residents are over the age of 80 (Statistics Canada, 2007), have substantial 
cognitive impairment (Rovner et al., 1990) and display multifaceted behavioral issues (Zwijsen 
et al., 2011) causing their medical care to be complex. HF is common among LTC residents with 
a prevalence of 20% and is coupled with significant co-morbidities, namely dementia, diabetes 
mellitus and COPD (Daamen et al., 2010). LTC residents with HF incur higher annual mortality 
and hospitalization rates of 42% and 31% respectively, compared to 24% and 27% in the non-HF 
LTC population (Foebel et al., 2013). Furthermore, temporal trends show that despite a reduction 
in hospital length of stay and in-hospital mortality, 30 day readmission rates from LTC have 
increased to almost 20% between 1993 and 2006 (Bueno et al., 2010).   
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2.3.1 Management Challenges  
 Given the adverse outcomes highlighted above, timely diagnosis and appropriate 
management of HF have potential to optimize quality of life and reduce HF-related 
hospitalizations and complications. There are a number of therapies, both self-directed and 
pharmaceutical, which can reduce the risk of hospitalization and death. Interested readers are 
referred to relevant guidelines for more information (Arnold et al., 2006; Keteyian et al., 2012, 
Abdulla et al., 2006; McKelvie et al., 2012; Packer et al., 2001; Faris et al., 2002). 
 Despite the foregoing, optimal management of HF in older persons according to best 
practice guidelines (Hancock et. al, 2014), is impeded by a number of barriers. Notably, 
physicians in primary care cite a hesitancy to prescribe recommended therapies to patients who 
are elderly, frail and have many comorbidities and polypharmacy (Fuat et al., 2003). Additional 
barriers in LTC include a lack of defined inter-professional responsibilities, negative 
assumptions surrounding the acceptability of interventions (Close et al., 2013) as well as 
insufficient access to diagnostic equipment and specialists (Strachan et al., 2014). Importantly, 
primary care and LTC physicians often cite a lack of confidence in establishing an accurate 
diagnosis of the condition (Phillips, Tofler and Martin, 2014; Khunti, Hearnshaw, Baker & 
Grimshaw, 2002).  
 Low diagnostic confidence of HF among clinicians is common. A focus group study 
found that 95% of cardiologists, 93% of internists, 66% of general practitioners and 32% of HF 
nurses cited confidence in diagnosing HF-REF. For HF-PEF, confidence levels were much lower 
with percentages for cardiologists, internists, general practitioners and HF nurses being 58%, 
43%, 7% and 6% respectively (Hancock et al., 2014).This study was conducted in the United 
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Kingdom where general practitioners are equivalent to Canadian family physicians who most 
often practice in primary care and LTC. 
 The Canadian Cardiovascular Society asserts that optimal management of HF is hinged 
upon an accurate, timely diagnosis (McKelvie et al., 2013). However, low diagnostic confidence 
can delay identification of the condition and thus lead to adverse outcomes.  
2.4   Diagnostic Accuracy and Challenges  
 Accurate diagnosis by family physicians is essential as the majority of patients with HF 
live independently in the community and only present to the larger hospital setting when 
symptoms become severe (Gillespie, 2006). Low diagnostic confidence or an inaccurate 
diagnosis can delay the initiation of treatment and account for the poor outcomes observed in the 
HF population. This section seeks to quantify the impact of low diagnostic confidence on 
accuracy, and to present challenges in identifying HF.      
2.4.1 Prevalence of Undiagnosed and Misdiagnosed HF 
 In primary care, HF cases often go either undetected or are misdiagnosed. A cross 
sectional study found that 16% of patients had previously unrecognized HF when using the 
European Society of Cardiology's diagnostic guidelines (van Riet et al., 2014). HF is sometimes 
also over-diagnosed (Sparrow, Adlam, Cowley & Hampton, 2003). A retrospective review 
showed that HF was unlikely in 30% of patients previously thought to have the condition. The 
main syndromes responsible for false positive diagnoses were obesity, unrecognized 
symptomatic myocardial ischemia (without HF) and pulmonary disease (Remes, Miettiene, 
Reunanan & Pyorala, 1991).     
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 In LTC, diagnostic accuracy for HF is often worse. Barents et. al (2008) conducted a 
cross-sectional study examining the number of misdiagnosed HF cases. They showed that 
approximately 62.5% (15 of 24) of patients deemed to have HF were previously undetected. At 
the onset of the study, of 22 patients thought to have HF, 60% (13) were incorrectly diagnosed. 
These findings were corroborated by Bolmsjö et al. (2013) whose study explored the prevalence 
of HF in Swedish nursing homes with special focus on HF diagnoses. Of the 429 residents in the 
study, 196 had suspected HF (based upon BNP >100 ng/L) yet, only 66 had the diagnosis in their 
chart. The findings show that 154 of 363 residents (42%) who were deemed to not have HF had a 
mean BNP of 143.2 ng/L and should have undergone further examination for potential HF. As 
one year mortality was similar between suspected HF group and diagnosed HF, the authors 
surmised that this could indicate a high rate of undetected HF. The probability of appropriate 
pharmacotherapy increased if the correct diagnosis was in the patient record (Bolmsjö et al., 
2013).  
 Only one study in LTC was found to clearly differentiate between HF stemming from 
HF-REF and HF-PEF. Hancock et. al (2012) found that half of the overall HF cases using the 
European Society of Cardiology guidelines was previously undiagnosed and 75% of previously 
diagnosed HF at the onset of the study were unconfirmed. When distinguishing between the two 
types, HF-PEF was previously undiagnosed in 90% of cases. Not only is HF under-diagnosed but 
it is often uncharacterized and medical records were found to not specify the type or severity of 
HF in 99% of cases (Hancock et al., 2012). 
2.4.2 Diagnostic Challenges  
 Detection of HF early in its trajectory may be difficult as symptoms are often unreported 
by patients or misattributed to aging. A study conducted in LTC found that 11 of 15 de novo HF 
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cases were overlooked due to mild symptoms and the remaining four were missed due to 
multiple comorbidities leading to confusion and ascription of symptoms to non-cardiovascular 
causes (Barents et al., 2008). Varied symptom presentation was also noted by Hancock et. al 
(2012) as leg edema, dyspnea and breathlessness appeared to have little diagnostic utility in the 
LTC population. Furthermore, Valle et al. (2005) found that most patients were asymptomatic as 
only 23% cited dyspnea and/or ankle edema.    
 COPD presents clinically in a similar fashion to HF. If signs and symptoms are 
exclusively attributed to COPD, underlying HF may be undetected. A study recruited community 
dwelling patients who had COPD diagnosed by their general practitioner and did not have a 
cardiologist. The participants underwent an extensive diagnostic work-up and of the 405 patients, 
83 had previously unrecognized HF (Rutten et al., 2005). In LTC, Barents et. al (2008) attributed 
the main reason for an incorrect diagnosis to a previous history of atrial fibrillation and COPD. 
 Poor clinical skill proficiency can contribute to the diagnostic difficulties involved with 
HF. Physicians expressed a lack of confidence in their clinical skills and inappropriately rely on 
echocardiography to establish a diagnosis (Heckman et al., 2014). Given the limited access to 
investigative tests in primary care and LTC, confidence and accuracy of diagnosing HF in part 
lie in improving the assessment of the JVP.  
2.5   Significance of Signs and Symptoms 
 Clinical history and physical examination are the cornerstones of establishing a diagnosis 
of HF (Cubero, Rivera, Moral & Melchor, 2004), thus making the evaluation of clinical signs 
and symptoms crucial. This section seeks to outline the value of the signs and symptoms and 
how they can be used in the differential diagnostic process. 
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2.5.1 Medical History and Symptoms  
 A thorough medical history can identify the contributing factors of a suspected HF case 
and establish their severity. Assessments such as the Minnesota Living with Heart Failure 
questionnaire (APPENDIX ii) have been developed to help physicians identify disease severity 
or quantify changes over time. Clinical questionnaires, namely the Walma, Framingham, Boston, 
Goteborg,  Gheorghiade, Duke and NHANES-I show good concordance and can help in 
attributing HF signs and symptoms to other causes as they are highly specific (range from 80% 
to 98%). However, their low sensitivity (35% to 65%) limit their potential in diagnosis (Fonseca 
et al., 2004).  
 The cardinal symptoms of HF are dyspnea, initially on exertion and eventually at rest, 
orthopnea, paroxysmal nocturnal dyspnea and peripheral edema. As previously discussed, these 
symptoms may be mild, and in the most subtle end of the spectrum, patients might lack 
symptoms altogether (Fonarow et al., 2008). Symptoms of HF are generally insensitive with 
varying degrees of specificity, with the exception of dyspnea.  It is a commonly reported 
symptom among HF patients and has sensitivity, specificity and positive predictive values of 
92%, 19% and 79% respectively. Patients with dyspnea at rest were 13% more likely to have HF 
(Ahmed, Allman, Aronow & DeLong, 2004). Although findings have been notably 
heterogeneous, pooled results for dyspnea cite a sensitivity of 83% and specificity of 54% (Mant 
et al., 2009). Orthopnea has good specificity in some instances but studies have reported varied 
estimates ranging from 60% to 95% while sensitivity is 44%. Similar to orthopnea, paroxysmal 
nocturnal dyspnea (PND) has relatively good specificity but is insensitive, though estimates are 
heterogeneous (Mant et al., 2009). Dyspnea on exertion, orthopnea and PND are uncommon 
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(Ahmed, Allman, Aronow & DeLong, 2004). Edema, classified as either a sign or symptom has 
a sensitivity of 53% and specificity of 73% (Mant et al., 2009).          
 HF patients may present with a wide assortment of other symptoms including 
palpitations, lightheadedness and syncope. This myriad of symptoms complicate the differential 
diagnostic process as they are sometimes attributed to bronchitis if in conjunction with a dry 
cough or asthma if wheezing is present (Mann, 2011). And, as noted previously, frail seniors 
with HF, such as those who reside in LTC, often present with geriatric syndromes rather than the 
cardinal features of HF. 
2.5.2 Physical Examination 
The purpose of the physical examination is to aid in identifying the presence of disease, 
determining the cause and severity, hemodynamic profile, response to therapy, and prognosis. 
The majority of HF signs have good sensitivity but poor specificity with the JVP being a notable 
exception. For example, tachycardia has poor sensitivity and widely varying estimates of 
specificity (92%, 82% and 40%) (Mant et al., 2009). 
 A third heart sound (S3) is audible in some patients at the apex of the heart and could be 
indicative of volume overload, restrictive filling, aortic and mitral regurgitation (Tribouilloy et 
al., 2001). It is a very specific sign at 99% but not sensitive at 24% (Shamsham & Mitchell, 
2000; Mant et al., 2009). Thus, if the sign is present, it helps to rule the disease in but if absent it 
does not rule the disease out. In combination with jugular vein distension, a third heart sound 
portends an especially poor prognosis (Drazner, Rame, Stevenson & Dries, 2001) and disease 
progression (Drazner, Rame & Dries, 2003).   
 Auscultation of the pulmonary system may uncover the presence of crackles. However, in 
spite of pulmonary congestion, crackles may be absent because of increased lymphatic drainage 
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and compensatory changes in the perivascular structures that have occurred over time. In some 
cases, wheezing may be the only manifestation of pulmonary congestion and this leads to asthma 
or COPD being frequently and erroneously diagnosed in patients who actually have HF 
(Shamsham & Mitchell, 2000). Lung crackles are associated with 51% sensitivity and 81% 
specificity (Mant et al., 2009).   
2.6 Importance of JVP  
 The majority of studies investigating JVP have reported heterogeneous results or 
inadequate descriptions of how the measure was obtained to allow for comparisons. Systematic 
reviews cite poor sensitivity and moderate specificity of JVP with values of 52% and 70% 
respectively. However, only one study (of seven) reported how the JVP was quantified and 
reported a specificity of 99% and sensitivity of 24% (Fonseca et al., 2004).  Furthermore, 3 items 
from history (age, coronary artery disease, and loop diuretic use) in addition to 6 from physical 
examination (pulse rate and regularity, displaced apex beat, crackles, heart murmur, and 
increased JVP) showed high independent diagnostic value for HF (Kelder et al., 2011). The signs 
that best predicted the diagnosis of HF were JVP greater than 6 cm with hepatic enlargement and 
edema, S3 gallop, a heart rate greater than 110 bpm and crackles. Finally, the JVP has prognostic 
utility with elevated levels being associated with HF related hospitalizations and increased 
probability of death (Drazner, Rame, Stevenson & Dries, 2001). Accordingly, assessment of the 
JVP figures prominently in numerous guidelines and diagnostic criteria for HF.   
European Society of Cardiology 
 The guidelines acknowledge that the diagnosis of HF especially in the early stages may 
be difficult, due to signs resulting from sodium and water retention, obesity, advanced age, and 
even chronic lung disease. To establish “suspected HF”, relevant symptoms and signs, one of 
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which being elevated JVP, need to be present. The guidelines do not indicate a specific cutoff to 
quantify "elevated JVP".    
American College of Cardiology 
 The 2013 American College of Cardiology/American Heart Association 
Recommendations state that an elevated jugular venous pressure is the most useful sign of 
congestion (Yancy et al., 2013).         
Canadian Cardiovascular Society  
 For acute HF, the 2012 CCS guidelines prefer the PRIDE scoring system (APPENDIX 
iii) or Boston criteria to establish the likelihood of HF. The PRIDE score does not utilize JVP, 
which figures prominently in the Boston criteria. It is important to note that the guidelines 
emphasize basic evaluations that are widely available and place less value on advanced tests 
which should be reserved for selected, medically complex patients. Although not explicitly 
mentioned, the CCS criteria categorized the assessment of JVP under the volume status 
component of physical examination found in APPENDIX iv.  
Framingham criteria 
 The Framingham criteria (TABLE 1) require a minimum of two major or one major and 
two minor criteria be present concurrently. The Framingham criteria treat an elevated CVP 
defined as greater than 16 centimeters of water or neck vein distention as major criteria (Maestre 
et al., 2009).  
TABLE 1 – FRAMINGHAM DIAGNOSTIC CRITERIA FOR HEART FAILURE 
Major Criteria  Minor Criteria 
Paroxysmal nocturnal dyspnea or orthopnea Bilateral ankle edema 
Neck-vein distention Nocturnal Cough 
Rales Dyspnea on ordinary exertion 
Cardiomegaly Hepatomegaly  
Acute pulmonary edema Pleural Effusion 
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S3 gallop Vital capacity decreased one third from 
maximum 
Increased central venous pressure (> 16 cm 
H2O) 
Tachycardia (heart rate >120/min) 
Circulation time (> 25 seconds)  
Hepatojugular reflux  
Weight loss (> 4.5 kg in 5 days in response to 
treatment) 
 
Source: (Maestre et al., 2009)  
Boston 
 The Boston criteria (TABLE 2) utilize a scoring scheme whereby elements of the clinical 
history, physical examination and chest radiograph are scored and then classified under the 
categories of “Definite HF” for total scores including and between 8 and 12 points, “Possible 
HF” if between 5 and 7 points and “unlikely HF” if  ≤ 4 points. A JVP of greater than 6 
centimeters of water in isolation is associated with two points, and three points in the presence of 
edema or hepatomegaly. Considering that the range of possible HF is from 5 to 7 and definite HF 
from 8 to 12, an elevated JVP is one of the most influential signs from the physical examination 
contributing to the HF diagnosis (Marantz et al., 1988). 
TABLE 2 – BOSTON CRITERIA    
Category Criteria Score 
 
 
Clinical History 
 
Dyspnea  
 
At rest 4 
On level ground 2 
While climbing 1 
Orthopnea  4 
Paroxysmal nocturnal dyspnea 3 
 
 
 
 
 
 
Physical 
Examination 
 
Heart rate 
 
91-110 beats/min 1 
110 beats/min 2 
Jugular Venous 
Pressure ( > 6 cm H2O) 
Alone 2 
Hepatomegaly or edema 3 
 
Rales/Crackles  
 
Basilar Crackles 1 
More than Basilar 
Crackles 
2 
Wheezing  3 
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S3 Gallop 3 
 
 
 
Chest Radiograph 
Alveolar pulmonary edema 4 
Interstitial pulmonary edema  3 
Bilateral pleural effusion  3 
Cardiothoracic ratio > 0.5 (posteroanterior 
projection)  
3 
Upper flow Distribution  2 
Source: (Mann, 2011) 
2.7 Clinical Assessment of JVP  
CVP can be measured invasively at the junction of the superior vena cava and right 
atrium by insertion of a catheter. Alternatively, it can be measured non-invasively by 
approximating the height of the JVP above the chosen landmark (Izakovic, 2011). It should be 
noted that there is considerable variability in clinical recommendations of the technique, cut off 
values, and classification used to assess JVP.   
2.7.1 Anatomical Considerations  
Internal versus External Veins 
There is a difference in opinion among medical educators and clinicians whether the 
internal or external jugular vein is best suited for observation of JVP. Both have specific 
strengths and weaknesses and there appears to be little consensus as to which supersedes the 
other in terms of importance. Some clinical researchers have exclusive preferences while others 
agree that using either vein is sufficient. The position of the two veins can be visualized in  
FIGURE 2 below. 
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FIGURE 2 - INTERNAL AND EXTERNAL JUGULAR VEINS  
 
 
 
 
 
Source: http://medical-dictionary.thefreedictionary.com 
The above figure shows that the internal jugular vein (IJV) runs more medially than the 
external jugular vein (EJV). It travels down the inside of the neck and outside the internal and 
common carotid arteries, uniting with the subclavian vein to form the brachiocephalic vein. 
Traditionally, the internal vein is most often recommended in medical textbooks and literature as 
it forms a direct conduit with the superior vena cava and contrary to the EJV, does not undergo 
two right angle turns (Constant, 2000). It is believed that this allows for a more accurate 
estimation of JVP. However, as the IJV is located deep beneath the sternocleidomastoid muscle, 
it is often difficult to see and differentiate from the carotid artery (Vinayak et al.,2006).     
Alternatively, the EJV is lateral to the IJV and superior to the sternocleidomastoid 
muscle, traveling to the base of the neck where it joins the subclavian before emptying into the 
superior vena cava. Proponents of the IJV state that the EJV is similarly just as difficult to 
visualize and unhelpful in detailed examinations (Constant, 2000; Ahmed, Jones and Hays, 
2008). In other cases, the external jugular vein has been noted as being significantly more easily 
observed than its internal counterpart and can differentiate between low and high levels of CVP 
(Vinayak et al., 2006).  
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Braunwald's eighth edition of cardiovascular medicine contends that the IJV is preferred 
as the EJV contains valves and is not directly in line with the superior vena cava and right atrium 
(Libby, Bonow, Mann & Zipes, 2008). However, the IJV also has competent valves which may 
in fact, obscure accurate estimations of the JVP by preventing reflux of venous blood from the 
right atrium (Silva, Deen, Fernando & Sheriffdeen, 2002). There is considerable anatomical 
variability and the physiologic impact of these variables remain unconfirmed (Valecchi et al., 
2010)   
An overview article pertinent to the JVP in acutely ill patients found a high level of 
agreement between physical examination of JVP and catheterization regardless of whether the 
internal or external vein was observed (Garg & Garg, 2000). 
Right versus Left Sided Veins  
 Another anatomical consideration relates to whether the jugular vein on the left or right 
side of the neck provides the best option for observation. During periods of modest inspiration, 
the descending diaphragm and aorta relieve the partial compression of the left brachiocephalic 
vein making the pressure within the two internal jugular veins equal. However, partial 
compression of the left brachiocephalic vein by the aorta may occur, particularly in older 
patients, impairing transmission of the accurate right atrial pressure to the left brachiocephalic 
vein. This is the most common cause of unequal pressures. As the right brachiocephalic vein and 
IJV are in a direct line with the superior vena cava, it is believed that there is better transmission 
of right atrial pressure. Therefore, examination of the right jugular venous pulse is preferred for 
assessing the hemodynamic changes in the right side of the heart (Post, 2015).  
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2.7.2 Lewis Method 
 The Lewis method is used to non-invasively measure JVP at the bedside. The first step 
requires identification of the jugular vein with the patient at a 450 upward tilt. The jugular pulse 
should be located by observation. Sometimes, extension of the patient’s chin might be needed to 
enhance the observation but care is necessary not to tense the sternocleidomastoid muscle 
excessively as this will compress the external and internal jugular veins, concealing their 
pulsations (Mann, 2011). 
 Following identification of the jugular vein, the height of the mean JVP is measured in 
cm of water above the midpoint of the right atrium, the standard reference point for 
hemodynamic measurements in the catheterization laboratory. To determine the mean JVP, the 
height of the venous column on inspiration and the crest of the column on expiration should be 
noted. The patient should be encouraged to avoid exaggerated breathing or holding their breath 
as this may exacerbate the pulse. A horizontal line should be drawn from the estimated height of 
the pulse to intersect a vertical line which is estimated to protrude from the sternal angle. The 
distance should be measured and when the obligatory 5 cm is added, this value represents the 
mean JVP (Mann, 2011). The addition of 5 cm represents a simple estimation often used to 
represent the distance between the sternal angle and the right atrium. The process can be 
accomplished with the use of two rulers as in depicted in FIGURE 3. 
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FIGURE 3 - MEASUREMENT OF THE JVP USING THE STERNAL ANGLE 
 
 
 
 
 
 
Source: (Walker, Hall & Hurst, 1980)  
 The clinician should observe the rise and fall of the venous pressure during normal 
inspiration and expiration. To confirm the measurement or if the jugular veins cannot be 
identified, the clinician should apply firm but persistent pressure over the liver for 10 seconds 
while observing the mean JVP, a maneuver known as the hepatojugular reflux (Mann,2011). In 
healthy individuals, this will incur a modest or no rise in mean JVP but, a positive reflux 
involves an increase in JVP of more than 3 cm H2O that are sustained for longer than 15 seconds. 
Although termed the hepatojugular reflux, pressure is not necessary directly upon the liver and 
thus is also referred to as the abdominojugular reflux (Karnath, Thornton & Beach, 2002). After 
determining the mean JVP, the clinician should attempt to determine the venous pulse contour by 
observing the venous pulse in right side of the neck (Mann, 2011). The hepatojugular reflux 
significantly increases the specificity of JVP (Libby, Bonow, Mann & Zipes, 2008).        
A variation of the Lewis method involves having the patient in a supine position on a bed 
elevated such that the peak of the right jugular pulsation can be observed. The angle of 
inclination is usually between 300 and 450. The physician should begin by placing the zero mark 
of the centimeter ruler at the midaxillary line and fourth intercostal space, a landmark known as 
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the phlebostatic axis which acts as an alternate reference point to the sternal angle. This axis is 
considered a true external reference point for the right atrium (Potger & Elliott, 1994). Using this 
landmark as the reference point places the zero mark at the level of right atrium, and the height 
of the jugular venous pulse should be measured vertically from this point. The ruler should be 
held perpendicularly to the floor. The JVP is the measured distance between the zero mark of the 
ruler and an imaginary line running parallel to the floor and extending from the highest point of 
pulsation of the right jugular vein as shown in FIGURE 4.  
FIGURE 4 - MEASUREMENT OF THE JVP USING THE PHLEBOSTSTIC AXIS 
 
 
 
 
 
 
 
 
Source: (Karnath, Thornton & Beach, 2002) 
As some patients with elevated CVP need to be raised more than 450  for the pressure to 
be estimated, clinicians frequently underestimate the value and it has been recommended that 
they simply determine whether the CVP is elevated or not, without attempting to make a specific 
measurement (Karnath, Thornton & Beach, 2002).  
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2.7.3 Reliability 
 JVP measures can be inaccurate leading to poor reliability (Stevenson & Perloff, 1989). 
This is because many practitioners of varying levels of seniority and experience do not measure 
it correctly, leading to a cycle of unreliable information, lack of confidence, and underuse. To 
this end, astute technique and a keen eye have been noted as vital to produce a reliable measure 
of the JVP (Chiaco, Parikh and Fergusson, 2013). When correlated to direct measurement, the 
bedside clinical estimation of CVP has been merely fair (McGee, 1998). Differing standards of 
reference, clinicians, numeric or categorical classification, and variable definitions of the normal 
range have limited comparison between previous studies (Libby, Bonow, Mann & Zipes, 2008).  
 Variability in measure has been a long standing concern in the bedside estimate of CVP. 
Agreement has been found to be greatest in the medical student to resident ratio (κ = 0.65) than 
student to attending physician (κ = 0.56) and resident to attending physician (κ = 0.30) (Cook, 
1990). Inter-observer variation and even intra-observer variation is substantial with discrepancies 
as large as 7 cm of H2O (Cook, 1990). A recent review study comparing physical examination to 
catheterization in acutely ill hospitalized patients found that clinicians were accurate in 50% of 
cases when classifying CVP as low, normal or high based on their JVP measure. Importantly 
however, accuracy was much better if the venous pressure was predicted to be high (77- 80% 
accuracy) as opposed to low (3- 38% accuracy) (Garg & Garg, 2000).  
 Assessing the JVP using the phlebostatic axis is thought to confer greater reliability 
owing to smaller degrees of variation in measurements caused by the patient’s posture. On 
comparing measurements performed in the emergency room to those in hospital, disparities were 
as great as 11.8 cm H2O when the sternal angle was used, compared to 9.1 cm H2O with the 
phlebostatic axis (Haywood, Joy & Camm, 1991).  
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In establishing the clinical criteria for the Framingham recommendations to establish a 
diagnosis of HF, inter-rater reliability between clinicians was assessed. The inter-rater reliability 
of neck vein distension classified dichotomously as high or low conferred fair to good reliability 
at 0.71 (Maestre et al., 2009).      
 The literature on the reliability of JVP measures is limited. The need for more rigorous 
investigations with clear descriptions of how the variable was measured with standard cutoffs (if 
categorically classified) has been acknowledged (Sankoff & Zidulka, 2008).   
2.7.4 Assessment Challenges 
The poor reliability of JVP measurements may persist because of multiple 
misconceptions among physicians and clinicians as outlined by Ahmed, Jones & Hays (2008). 
The first is the belief that only the internal jugular veins are useful in the estimation of JVP. As 
previously outlined, the internal jugular veins are difficult to observe as they lie behind the 
largest group of muscles in the neck, the sternocleidomastoids. These muscles can obscure an 
accurate observation of the vein leading to an underestimate or inability to obtain a measure 
altogether (Curtis et al., 2005). Research findings have shown that the EJV is indeed easier to 
visualize than the IJV and depicts strong agreement with low and high CVP (Vinayak et al., 
2006). 
 Secondly, there is a mistaken belief that patients must be positioned at a 450 incline and 
that the distance between the right atrium and sternal angle should always be 5 centimeters 
regardless of body position. A visible jugular pulsation in the neck at 450could be misleading as 
it is rendered useless when the pressure is too high (top of the jugular pulsation behind the angle 
of jaw) or too low (top of the jugular pulsation behind the clavicle). Thus, it is recommended that 
patients be either in a supine position, sitting position or any other position in between that 
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allows for the observation of the height of the pulse. Ideally, if the top of the jugular pulsation is 
above the level of the sternal angle, that distance should be added to the estimated distance 
between the sternal angle and right atrium. On the other hand, if the top of the jugular pulsation 
is below the level of the sternal angle, this distance should be subtracted from the estimated 
distance between the sternal angle and right atrium (Ahmed, Jones and Hays, 2008).  
 The addition of 5 centimeters to the raw measure has been questioned. The sternal angle 
or notch is an anatomical landmark and depending on the position of the patient, can be a 
variable number of centimeters above the approximate location of the right atrium. At the 
recommended 450 upward tilt from the horizontal, the distance in vertical height can range from 
5 to 10 centimeters. If the patient is tilted progressively upward towards 90O, the distance can be 
as great as 12 centimeters. A recent study using computed tomography (CT) scan measurements 
in 160 patients to determine the distance between the sternal angle and the level of the right 
atrium, found the median value for the vertical distance was 5.4 cm in the supine position. 
However, when the CT images of the torso were rotated to 300, 450 and 600, the median vertical 
distances were 8, 9.7, and 9.8 cm, respectively (Seth, Magner, Matzinger & Walraven, 2002). 
Patients have been known to display wide variations in height at respective degrees with a range 
of 5 to 13 cm at 30º for example. It has been recommended that 10 cm should be added if the 
torso is elevated greater than 450 (Devine, Sullenberger, Bellin & Atwood, 2007). These 
differences highlight the exactness required to reproduce precise measures. 
Other notable factors contributing to the poor reliability of the measure include variations 
in the positioning of patients, poor ambient lighting, difficulty in differentiating carotid from 
venous pulse, biologic variation in CVP with projects of respiration and the effects of 
vasoconstrictive medication and diuretics (Cook, 1990). Although the Lewis method suggests 
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that the measure be quantified numerically, studies have posited that normal JVP levels can be 
defined when the blood column is not visible. However, this classification is imprecise and slight 
elevations of JVP would be inaccurately labeled as "normal".  It has been postulated that this 
categorization could account for apparent low sensitivity of elevated JVP for diagnosing HF 
(Laar, 2003). 
Despite the possibility of using JVP measures to diagnose HF as evidenced above, the 
assessment of JVP has been devalued by the European and Dutch societies of cardiology mainly 
because the method is difficult, requiring substantial training and experience (Laar, 2003). This 
suggests that relying solely on improving clinical skills may be impractical in busy primary care 
and LTC settings. The following section reviews the use of POC devices to assess the JVP in 
primary care and LTC.  
2.8  POC Devices and the Mespere Venous 1000 CVP System 
2.8.1  POC Devices 
 POC testing is defined as medical testing at or near the site of patient care. These tests 
can vary from simple medical blood tests to urine test strips, ECGs, O2 saturation, heart 
rate measurement and imaging such as with a portable ultrasound device (Kost, 1995). Family 
physicians in the UK, USA, Netherlands, Belgium and Australia have endorsed the use of POC 
devices to aid diagnosis, although the focus was mainly on acute conditions (Howick et al., 
2014).      
 POC testing offers many benefits and reduces the turnaround time from testing to results, 
allowing for more effective patient triage and improved care. Some POC tests have been shown 
to simplify test procedures, reduce the chance of operator error, and utilize a blood sample that 
does not require pretreatment (Chan et al., 2013). Already deemed equivalent to traditional 
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laboratory tests in diagnosing type 2 diabetes (Lovrenčić et al., 2013), POC tests provide the 
potential of rapid diagnosis, risk stratification and management of patients presenting with 
symptoms consistent with HF (Christenson, Collinson, deFilippi and Christenson, 2014).  
 Mini-echocardiograms, smaller in size than traditional devices and used at the bedside, 
have been identified as a comparable measure to the clinical assessment of JVP. Although it 
requires less instruction, use of the device necessitates clinician interpretation as well as 
evaluation and assessment of its use (Rizkallah et al., 2014). Furthermore, a study comparing two 
different techniques for measuring JVP byway of ultrasonography performed at the bedside 
found a high degree of inter-rater reliability in emergency room patients (Socransky et al., 2009).  
 To date, no other POC device or technique has been used to measure the JVP. Despite the 
fact that the Mespere Venous 1000 CVP System was approved by Health Canada and the Food 
and Drug Agency for commercial use, its role in primary care and LTC remains unexplored.  
2.8.2 Mespere Venous 1000 CVP System  
 The Mespere Venous 1000 CVP System outputs a JVP measure and plethysmographic 
waveform in real time. It utilizes near-infrared spectroscopic light through an adhesive patch 
which is placed on the external jugular vein. As shown in FIGURE 5, a reference patch is placed 
at the phlebostatic axis. 
FIGURE 5 - PATCH PLACEMENT FOR THE MESPERE VENOUS 1000 CVP SYSTEM 
 
 
 
 
 
Source: (Mespere LifeSciences Inc., 2013) 
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            The system also consists of the handheld component, docking stand and cable. The 
handheld is compact and has a battery which provides eight hours of continuous use. The 
docking stand serves as a charging and calibration station.  The handheld is depicted in  
FIGURE 6. 
FIGURE 6 - HANDHELD COMPONENT FOR THE MESPERE VENOUS 1000 CVP SYSTEM 
 
 
 
 
 
 
 
Source: (Mespere LifeSciences Inc., 2013) 
           The device allows for output in either centimeters of water or millimeters of mercury. To 
measure JVP, the patch has to be placed on the external jugular at the height of the pulse. To 
facilitate for this, once the patches are placed on the patient, the device will prompt the clinician 
to either incline or recline the patient. If on a mechanical bed, this can be done automatically. In 
other instances, positioning the patient may need to be manually performed. A comprehensive 
step by step device protocol can be found in APPENDIX v.    
 Previous studies have shown a strong correlation between JVP measured by the device 
and right heart catheterization (Correlation r = 0.89, p<0.001; Accuracy 2.17 mmHg). The study 
recruited HF or pulmonary hypertension patients at a tertiary medical centre receiving 
catheterization as part of their usual care (Hoyt & Koelling, 2013). Another study found that the 
Mespere device detected greater variation in right atrial pressures in comparison to 2D 
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transthoracic echocardiography in a hospital based population (Levitt, Evangelista & Chow, 
2014).   
 The prognoses of HF patients can be significantly improved if a diagnosis is timely and 
accurate. However, significant barriers inherent to HF, the older adult population, and primary 
care clinicians exacerbate the diagnostic accuracy of the condition. One of the most specific 
signs, an elevated JVP is underutilized or often incorrectly measured. Interventions to improve 
clinical skills among primary care and LTC physicians, particularly with respect to the JVP, are 
certainly a consideration but may be impractical in such busy settings. The Mespere Venous 
1000 CVP System is a non-invasive, POC device which measures JVP. It is important to 
establish the acceptability and feasibility of using the device in primary care and LTC. 
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CHAPTER 3 
METHODOLOGY 
                  Accurate and timely diagnosis of HF is essential for its effective management. An 
elevated JVP is one of the most useful signs for diagnosing and managing HF, but is underused 
or used inaccurately in primary care and LTC settings. The Mespere Venous1000 CVP System 
has the potential to improve that assessment of HF in these settings.  
3.1 Research Questions  
This investigation followed an exploratory design. The aim of the study was to assess the 
acceptability and feasibility of using the Mespere Venous 1000 CVP System to measure JVP for 
diagnosing and managing HF in primary care and LTC. Specific questions included: 
1. What is the perceived understanding of the JVP among primary care and LTC 
clinicians? 
2.  How do clinicians in primary care and LTC perceive the acceptance of the Mespere 
CVP 1000 System to measure JVP? 
3. How do clinicians in primary care and LTC perceive the ease of use of the Mespere 
CVP 1000 System to measure JVP?  
4. What do clinicians in primary care and LTC perceive as barriers to the 
implementation and use of the Mespere Venous 1000 CVP System?  
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Based on emerging findings during the assessment of the acceptability and feasibility of 
using the Mespere Venus CVP 1000 System in LTC during the first project (Project i) of the 
investigation, the following two questions were added in a second project (Project ii): 
5. What is the inter-rater reliability of the Mespere Venous CVP 1000 System when 
used by LTC nurses?  
6. What is the inter-rater reliability of the Lewis method to measure JVP when applied 
by physicians in LTC?  
3.2 Project i Design   
This project employed an exploratory, descriptive design. The concepts of acceptability, 
ease of use and perceived barriers stem from the Technology Acceptance Model (TAM). This 
model suggests that when users are presented with a new technology, a number of factors 
influence their decision about how and when they will use it, perceived usefulness and perceived 
ease of use. Perceived usefulness is defined as the degree to which a person believes that the use 
of a system will improve performance while perceived ease of use refers to the degree to which a 
person believes that the use of a system will be effortless (Hauser & Shugan, 1980). The 
overarching goal of TAM is to predict acceptability. The model postulates that the use of a 
device is determined by the behavioral intention, but on the other hand, that the behavioral 
intention is determined by the person’s attitude towards the use of the system and also by his 
perception of its utility (Davis, 1986).     
Acceptability and perceived barriers are not distinct and acceptability may to a significant 
degree be influenced by the number and magnitude of perceived barriers. Acceptability is 
defined as the general view or attitude towards treatment operationalized in terms of judgment 
(Lebow, 1987). Participants' perceptions of the device could have derived from many factors 
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including but not limited to: personal values and beliefs, professional orientation, role, 
theoretical knowledge, practical training acquired through formal and continuing education, 
experience, availability and use of best practice guidelines (Sidani & Braden, 2011). Assessing 
acceptability was crucial as participants who perceived the device as acceptable would develop 
enthusiasm for it, offer it to peers, utilize it on patients assigned to their care, encourage and 
support its use and deliver it with fidelity. These are positive outcomes that would ensure that the 
device will be used effectively if implemented (Sidani & Braden, 2011). Alternatively, if 
clinicians perceived the device as less acceptable, they might not adopt it even if it were proven 
to be effective (Severy, Tolley, Woodsong & Guest, 2005). Acceptability is distinct from but 
precedes concepts of satisfaction and continued use. In lieu of these factors, the aim of an 
acceptability analysis in the context of this study was to focus on how the targeted audience, 
nurses and physicians in primary care and LTC would react to the prospect of integrating the 
device into their care setting (Sidani & Braden, 2011). This conceptualization allowed 
acceptability to be assessed at the time of potential implementation design and decision making, 
prior to actual device implementation. Acceptability is also distinct but related to concepts of 
appropriateness and usefulness. Participants may accept the device due to perceived intended 
purposes of use.    
 Perceived ease of use is defined as the degree to which a person believes that using a 
particular system would be free from effort and is a component of a usability analysis (Sidani & 
Braden, 2011). Its acknowledgement is a key component in human factor engineering science 
and research suggests that new technologies should be easy to use for end users. It has been 
observed that technology usability and ease of use are recognized as necessary components to 
38 
 
ensure that new technologies are used effectively; as evidenced by the number of recent 
publications on the topic in the healthcare literature (Karsh, 2004). 
 The consultative deductive approach was considered appropriate to achieve the objectives 
of this project as it allowed for input of key stakeholders (LTC and primary care nurses and 
physicians) to be obtained in regards to the appropriateness, relevance and usefulness of newly 
developed interventions or in this case, a novel device. The methodologies put forth by Sidani & 
Braden (2011) recommended group or individual interviews involving an interactive discussion. 
The following steps provided the basis upon which the training module and focus groups were 
structured: 
1) Review the clinical problem requiring intervention; 
2) Provide an overview of the selected intervention including its components, mode of 
delivery and dose; 
3) Describe in detail, potential aspects of the intervention, setting and timing of delivery;  
4) Ask interviewees to comment on the relevance of the device to their practice; 
5) Request interviewees to appraise the overall device for appropriateness and 
usefulness in addressing the preset problem and its suitability to the target population; 
and 
6) Ask interviewees to suggest ways of modifying the intervention and/or additional 
content, activities or techniques to enhance comprehensiveness and acceptability of 
the intervention. 
 Some components outlined in the above steps were not relevant to the device. For 
example, instead of the interviewer describing the mode of delivery, setting and timing of the 
intervention, those views were elicited from the participants in order to elicit previously 
39 
 
unconsidered implementation ideas. The impact of adopting the device into routine practice can 
be tested in a future efficacy and effectiveness intervention, for which the acceptability study 
would serve as a foundational layer. 
 The study was submitted to and received ethics clearance from a Research Ethics Board 
of the University of Waterloo. 
3.2.1 Recruitment and Setting 
 For the primary care nurses and physicians, the selected setting was the New Vision 
Family Health Team as it allowed for optimal convenience. The researcher coordinated the study 
with one lead physician and one NP. Those individuals disseminated information letters, consent 
forms as well as logistic information such as focus group location and times to their fellow staff 
members. Primary care nurses and physicians were recruited from this facility.  
 The recruitment of LTC physicians commenced with the researcher emailing executive 
directors in the local region with information letters, consent forms and a detailed explanation of 
the study. It was requested that they disseminate details of the study to their staff physicians. 
Interest on the part of executive directors was minimal. Even when disseminated, few physicians 
expressed a desire to participate. Due to the size and structure of LTC in the Kitchener-Waterloo 
region, most homes staffed two to three physicians. This made a single site focus group 
impractical as even with maximum participation, there would still be fewer participants than was 
recommended. To recruit from multiple sites would require the alignment of a number of logistic 
variables, namely convenience of scheduling and location. Therefore, instead of one focus group, 
the research student individually interviewed four LTC physicians who had voluntarily 
responded to a time, and location that were at their convenience.   
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 The recruitment of the LTC nurse participants commenced with the research student 
contacting the executive directors of LTC homes in the Kitchener-Waterloo area. The selection 
of the setting was based upon the interest expressed by the administration of the home and ease 
of facilitation. Parkwood Mennonite home was the selected location and nurses were recruited in 
a convenient manner.   
 The researcher coordinated the scheduling of focus groups with the facility directors and 
administrative staff to ensure that logistics such as location and time were at the convenience of 
the nurses. This was done in an effort to minimize barriers to participation. Recruitment and 
consent letters were sent to the nurses by the executive director of the home, inviting them to 
participate in the study two weeks prior to the scheduled data collection date. Recruitment and 
consent letters can be found in APPENDIX vi. In an effort to respect privacy and confidentiality, 
only the executive director was contacted for recruitment purposes. No communication was 
made with the nurses prior to the focus group. The research student followed up with the director 
to ensure that the materials had been disseminated and provided answers to any questions which 
had arisen. This helped to reduce the risk of a low participation rate.  
3.2.2 Data Collection Procedures  
 The primary collection method employed for this component of the study was focus 
groups. Focus group design and format were adopted from the recommendations put forth by 
Krueger and Casey (2000). The authors defined a focus group as “a carefully planned series of 
discussions designed to obtain perceptions on a defined area of interest in a permissive, 
nonthreatening environment” (Krueger & Casey, 2000, page 5). Focus groups offer many 
advantages and are well suited to encourage participation from those who are reluctant to share 
information in one on one interview settings. This technique allowed the researcher to observe 
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interpersonal communication and to highlight cultural values and norms within the group 
(Kitzinger, 1995). Focus groups were chosen to address the first four research objectives. Verbal, 
qualitative dialogue allowed for the participants to offer their perceptions and insight addressing 
ease of use and barriers to implementation. Using focus groups to explore perceived acceptability 
a priori to device implementation is supported by Sidani & Braden (2011).     
 Focus groups consisted of homogenous participants of characteristics relevant to the 
context of the study. A double-layer design was used. The first included two different personnel 
groupings: nurses and physicians. The second strata related to clinical setting: primary care and 
LTC. Focus group segregation was key to allow for the assessment of views towards other 
professional groups in that setting and professional scope of care. Krueger and Casey (2000) 
recommended that three to four focus groups should be conducted with each homogenous group 
until data saturation is reached. Data saturation is defined as the point at which additional data 
collection reveals no novel themes or patterns. However, due to limited resources and time 
constraints, one focus group per homogenized group was conducted.  As the objectives and 
results of the focus group present minimal risk or harm to individual participants or care 
facilities, it was deemed adequate to have fewer than recommended focus groups (Krueger & 
Casey, 2000). Given these provisos, it was safe to conclude that data saturation was reached 
when no new idea or suggestion was posed by the second group (physicians or nurses) in the 
same care setting and relevant to the same concept. If different themes continually emerged, 
additional focus groups and data collection would have been required. It was found, however, 
that this was not the case and four focus groups were sufficient for data saturation. 
 A sample size of six to eight individuals per focus group was considered appropriate by 
similar studies and literature assessing staff perceptions (Kitzinger, 1995). This number of 
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participants allowed for ample opportunity to share experiences and opinions, while at the same 
time being large enough to allow for a diverse range of perspectives (Krueger & Casey, 2000). 
 The focus group questions were developed iteratively having consulted medical and 
qualitative research experts in the field. Additionally, questions development was based on 
principles found in Creswell’s Qualitative Inquiry and Research Design (2007) and similar 
qualitative studies in the field found through PubMed (Ayala & Elder, 2011). An outline of the 
focus group questions can be found in APPENDIX vii. 
 In the context of this study, acceptability was guided by the participants' views on how 
the device addressed any difficulty in measuring JVP to diagnose and manage HF. In order to 
elicit these views, a thorough understanding of the device attributes was needed. Participants 
required knowledge of the nature of the device components, method of use, benefits or 
effectiveness in addressing the present problem and risks involved (Sidani & Braden, 2011). For 
this reason, a training module detailing the device protocol was delivered to each focus group 
and individual interview. The module was designed by the research student and manufacturers of 
the device, Mespere Life Sciences Inc. The module lasted approximately 30 minutes. It included 
a PowerPoint presentation which provided a step-by-step guide on how to operate the device, a 
definition of JVP, the Lewis method and how elevated levels can indicate HF among other 
conditions. The presentation was accompanied by a demonstration of how to use the device to 
measure JVP. The training module and demonstration were performed by the researcher. The 
aim of the module was to provide an overview of the device and brief introduction to the 
measure. Following this, the participants had an opportunity to practice using the device either 
on themselves or other focus group members who volunteered. An experimentation period was 
essential to allow for the observation of participants’ behavior while using the device and to 
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allow for informed opinions on device usability. This period lasted approximately thirty minutes. 
Immediately after completion, the focus group began with an outline of the study objectives, 
focus group length, recording, transcription, and confidentiality (Creswell, 2007). The total 
average time for the training module, experimentation period, and focus group was two hours. At 
the end of the focus group, participants were provided a feedback letter found in APPENDIX 
viii. 
 The one-on-one interviews followed a similar protocol. The LTC physicians had an 
opportunity to practice using the device on a volunteer or the research student.  
Collected data were in the form of observational field notes taken by a research assistant 
as well as transcribed focus group dialogues. The combination of observational notes and 
transcripts allowed for data source triangulation and increased validity. During the focus group 
and experimentation period, a research assistant observed nonverbal communication and took 
field notes while the facilitator guided the participants through the questions (Creswell, 2007).  
3.2.3 Method of Data Analysis 
Qualitative data obtained through the focus groups and individual interviews were 
converted to transcripts by the research student. Analyses of the transcripts and field notes were 
conducted using recommended procedures (Rabiee, 2004; Creswell, 2007) and began with the 
printing and thorough review of data sources. Concepts were identified using emergent and 
directed coding (Guest, MacQueen & Namey, 2012). Coded data were organized according to 
major categories and subcategories reflecting more specific perceptions. Categories of codes 
were color coordinated to group similar concepts and to organize the data, creating themes 
(Rabiee, 2004). Transcripts were analyzed with a particular focus on clusters of information 
relating to: i) perceived understanding of the JVP; and ii) ease of use, acceptability and perceived 
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barriers of the POC device. Throughout the qualitative data analysis, consideration was given to: 
words and their meaning, the context of comments made, frequency of comments, intensity of 
remarks, word use, and body language (Krueger, 1994). The transcripts were twice reviewed to 
ensure emergent codes were substantiated. If found to be unsupported, codes were disregarded. 
Each transcript was coded and analyzed before the next focus group was conducted. This 
allowed the research student and facilitator to develop emergent prompts and points of emphasis 
during subsequent focus groups. 
 To increase inter-coder consistency, a few initial transcripts were coded and discussed by 
the research student and assistant. The research student then proceeded to code the remaining 
transcripts. All codes and themes were reviewed and confirmed by a second coder. The 
researcher discussed any discrepancies and collaboratively agreed upon the final codes, 
categories, and identified themes for each group (Saldaña, 2013). The intent of the second coder 
was to reduce bias through subjectivity of the researcher’s interpretation.   
3.3   Project ii – Reliability Study  
 Project ii was conducted in order to determine the reliability of the device and to compare 
it to the reliability of measurements obtained by LTC physicians using the Lewis Method, thus 
addressing research questions 5 and 6. 
3.3.1 Measurement of Reliability  
          The significance of a measured variable is largely dependent on the extent to which 
clinicians and researchers can rely on the indicator being meaningful (validity) and accurate 
(reliability) of the physiologic or behavioural attribute. Reliability is the extent to which a 
measurement is error free and validity is the degree to which the measure quantifies or describes 
what it intends to measure.  
45 
 
 Reliability estimates stem from the variability or differences among measured quantities 
within a sample. Total variability is a composite of between subject variability and measurement 
error. These components can be estimated and a measure is thus considered reliable if a greater 
proportion of the total observed variability is represented by subject variability,  
Reliability = 
Subject Variability 
Subject Variability+Measurement Error
  
Measurement errors are subdivided into systematic or random error. Systematic errors can be 
corrected for with the addition or subtraction of a constant value (Portney & Watkins, 2009). 
Random error however, can vary greatly in unpredictable ways as it stems from a multitude of 
sources including fatigue, inattention, mechanical inaccuracy or simple mistakes in 
administration (Portney & Watkins, 2009). Statistically, variability is quantified by variance, 
making the formal definition of reliability,   
Reliability =  
σS
2
σS
2+ σE
2  
where, the subscript S and E denote subject and error respectively. As the denominator is always 
larger than the numerator, reliability is expressed as a coefficient ranging from 0 to 1 where 1 
represents minimal error and a perfectly reliable test. 
 Although it is recommended that establishing both intra-rater and inter-rater reliability be 
a minimum to establish a good test (Portney & Watkins, 2009), this may not be required. If 
inter-rater reliability contains all sources of error contributing to intra-rater reliability in addition 
to any differences that may arise between observers, then a demonstration of high inter-rater 
reliability would be sufficient to satisfy both concepts. However, if proven to be low, it is unclear 
whether this arises from differences between or within observers (or both), necessitating an 
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 intra-rater analysis (Streiner & Norman, 2008). For this reason, among others, an inter-rater 
analysis was chosen to be the focus of this project as it may prevent the need for a separate 
 intra-rater investigation. 
There are multiple correlation coefficients to indicate reliability but the Intraclass 
Correlation Coefficient (ICC) and Cohen's weighted kappa were utilized in this study as they 
best addressed the research objectives. The ICC was utilized as its calculation is based upon 
estimates obtained through an analysis of variance, reflecting both the degree of correspondence 
and agreement among raters. Numerous additional benefits of using the ICC include the ability 
to assess reliability among two or more ratings, flexibility as it does not require the same number 
of raters per subject and, although ideal for use with interval data, can be applied to ordinal. The 
ICC also supports the generalizability model proposed by Cronbach as an excellent 
approximation of reliability (Portney & Watkins, 2009). The generalizability theory states that 
variance in observed scores results as a myriad of factors including raters, subjects, testing 
conditions, administration of the test under specific conditions among others. These factors all 
impact variance and can be distinguished from random error, whereas classic reliability is 
undifferentiated and incorporates all sources of measurement error.  
 The Pearson product-moment correlation coefficient also known as Fisher's Interclass 
correlation coefficient is a measure based on regression analysis and used to describe the extent 
to which two variables can be described by a straight line. It is intended to convey association 
between two different classes of variables such as shoe size and height (Streiner & Norman, 
2008). However, correlation does not always convey agreement although it can provide insight 
into relative position and consistency of ranked scores. For this study, as is the case in many 
clinical scenarios, it was necessary to establish that both raters agreed on the measurements and 
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not just that they were proportionally consistent (Portney & Watkins, 2009). A Pearson 
correlation coefficient of 1.0 can indicate a perfect fit despite a non-zero intercept and slope not 
equal to 1.0. Alternatively, an ICC will yield a value of 1.0 if all measures on each subject are 
identical, indicating a slope and intercept of 1.0. Thus, the Pearson coefficient can be susceptible 
to providing a liberal and inappropriate estimate of reliability although in practice, it should 
coincide with the ICC if a large proportion of total error is considered to be random (Streiner & 
Norman, 2008).  
 Some clinicians have a preference for the categorical classification of JVP as opposed to 
numerically quantifying it. There have been a number of studies which have treated the variable 
dichotomously as elevated or normal while others have stated that it may be low, medium or 
high. For these reasons, data analysis for this project entailed a calculation of a weighted kappa 
using the 3 level classification of JVP. The weighted kappa as opposed to the traditional kappa 
allows for partial agreement. Weights are routinely arbitrarily assigned but it has been 
recommended that unless there are strong and previous justifications, the commonly used 
quadratic weighting scheme should be implemented (Streiner & Norman, 2009). With this 
scheme, the weighted kappa is exactly identical to the ICC that would be computed if the 3 levels 
were treated as numeric data points (Streiner & Norman, 2009).     
 
 
 
 
3.3.2 Sample Size   
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 The sample size calculation followed recommendations put forth by Fleiss (1981), 
Cicchetti and Sparrow (1981) and Streiner and Norman (2009). An ideal sample would be large 
enough to ensure that the standard error of the 95% CI is 0.1 or ± 0.05.  
𝑍𝑅 =
1
2
loge [
1+(k−1)R
1−R
] and 𝑍𝑅− =
1
2
loge [
1+(k−1)R−
1−R−
] 
Using the hypothesized reliability of R = 0.7, standard error of 0.1, 
R- = 0.7 - 0.1 = 0.6 and with two raters per subject (K= 2), 
𝑍𝑅 =
1
2
loge [
1+(k−1)R
1−R
]  =  
1
2
loge [
1.7
0.3
]= 0.8673 
𝑍𝑅− =
1
2
loge [
1+(k−1)R−
1−R−
] = 
1
2
loge [
1.6
0.4
]= 0.6931  
Standard error = ZR - ZR-= 0.8673 - 0.6931 = 0.174 
From this, the sample size equation can be utilized,  
𝑛 = 2 +
k
2(k−1)(ZR − ZRi)
2
 = 2 +
2
2(1)(0.174)2
= 2 + 33 = 35 
For this study, 35 patients were required based on the hypothesized reliability of 0.7 and standard 
error of 0.1.   
3.3.3 Recruitment and Setting  
 The study was submitted to and received ethics clearance from two separate committees, 
the University of Waterloo and the LTC home. The search for a suitable LTC home began with 
an environmental scan of homes in the Kitchener-Waterloo-Cambridge region. Emails were sent 
out to executive directors whose contact information was elicited from public websites. The 
homes were required to currently employ two or more physicians who were willing to volunteer 
their time either before or after their rounds at the home. Similar to Project i, the executive 
directors acted as the conduit through which information letters were passed on to physicians. 
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The research student conducted one-on-one meetings with physicians and executive directors to 
explain the study in detail if requested to do so. The two nurses were recruited from a local 
nursing school. The selected LTC home was People Care Hilltop Manor in Cambridge.  
 Prior to patient recruitment, a courtesy call was sent out to all family members of 
residents in the home explaining the study and that the research student would be approaching 
residents. The study was advertised in elevators and hallways. A brief description was included 
in the monthly newsletter of the home. The research assistant also held information sessions 
which residents or families were invited to attend.   
 Residents were recruited as a convenience sample. The research student only approached 
residents who could have cognitively provided consent (Cognitive Performance Scale - CPS - 
score of 2 or less) and whose cognitive status was confirmed by the nurses. There was no other 
exclusion criteria and for three potential patients, the information letter and consent forms were 
translated to Portuguese and Romanian by nurses who volunteered their time.  
3.3.4   Method of Data Collection 
           The two nurses underwent a one hour training module designed by the research student. 
The aim of the training was to teach the nurses how to use the device. It included a PowerPoint 
presentation with a step-by-step pictorial protocol for the device as well as suggestions on how to 
troubleshoot any errors which may occur during data collection. The nurses were also shown a 
five minute video on how to locate the anatomical landmarks required for device use. Following 
this, the two nurse raters had an opportunity to observe a demonstration of how to use the device. 
The demonstration was performed by a research assistant on a volunteer. Lastly, the nurses had 
an opportunity to practise using the device on volunteers. As data collection commenced a week 
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after the training, the nurses had additional practice trials immediately before collection to avoid 
confounding by a warm up effect.  
 The nurses did their measures in the evenings between 8:00PM and 10:00PM on 
Tuesday, Thursday and the occasional Monday. Those times were selected so as to minimize the 
inconvenience of having residents transition in and out of bed during the day. The nurse 
measures were in immediate succession. The maximum time between physician and nurse 
measures was forty eight hours. 
The two physicians were shown an eight minute video on how to assess JVP using the 
Lewis method. The goal of the session was to serve as a reminder of the maneuver specifics and 
was conducted by the researcher. Due to scheduling constraints, the physicians measured 
patients’ JVP after their regular rounds at the facility. For one physician, those times were on 
Monday, Tuesday and Thursday between 10:00AM and 11:00AM. For the second physician, 
collection times were on Tuesday and Thursday between 8:30AM to 10AM. The number of 
patients measured per day ranged from 0 to 6. Due to residents sometimes leaving the home for 
hospital visits or special tests, the maximal time between physician measures was forty eight 
hours.  
 Clinical data was abstracted from resident charts in order to characterize the sample.       
3.3.5 Method of Data Analysis 
 The intraclass correlation coefficient model 2,1 or ICC2(A,1) was used to measure 
 inter-rater reliability. A weighted kappa was used for the categorical classification of JVP and 
was calculated by using quadratic weights. The normal interval for JVP is from 4 to 8 cm H2O 
and the range can be from 2 to 25 cm H2O (Socransky et al., 2010). Intervals of 0 to 3, 4 to 8 and 
8 to 25 cm H2O represented the low, normal and high classifications respectively. All analyses 
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were conducted in SAS V.9.2 (The SAS Institute). The ICC2 (A,1) was calculated using a macro 
found in APPENDIX ix.  
3.4 Assumptions   
 In the study, the following assumptions were made a priori to the data collection projects.            
At the onset of data collection, it was assumed that primary care and LTC clinicians were aware 
of the JVP measure as a clinical sign. It was assumed that the focus group questions would have 
been able to collect information free from bias. During Project ii, it was assumed that the JVP of 
otherwise stable LTC residents did not inherently change over the 48 hour interval of the data 
collection.   
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CHAPTER 4 
RESULTS 
4.1 Project i  
 Three focus groups were held with 25 primary care nurses, physicians and LTC nurses 
while four individual interviews were conducted with LTC physicians. Sample sizes for the 
focus groups and interviews were as follows: Group 1 of LTC nurses (7 RPNs, 3 RNs), Group 2 
of primary care nurses (6 RPNs, 3 NPs), Group 3 of primary care physicians (6 MDs), and Group 
4 of LTC physicians (4 MDs). Results of the focus groups and interviews were categorized into 4 
distinct groups by care setting and professional role. This was done due to the unique 
experiences and impressions expressed by each group despite some overlap. Demographic 
information for the sample can be found below in TABLE 3. 
TABLE 3 - FOCUS GROUP PARTICIPANT DEMOGRAPHICS 
Characteristic Primary 
care 
physicians 
(n=6) 
Primary 
care nurses 
(n=9) 
Long term 
care nurses  
(n=10) 
Long Term 
Care 
Physicians 
(n =4) 
Total 
Gender      
Male 3  - - 2 5 
Female 3 9 10 2 24 
Age      
< 20 - - - -  
20-29 - 2 - - 2 
30-39 2 2 3 - 7 
40-49 3 1 3 - 7 
50-59 1 3 3 1 8 
>60 - 1 1 3 5 
Occupation      
Registered Practical Nurse - 6 7 - 13 
Registered Nurse - - 3 - 3 
Nurse Practitioner - 3 - - 3 
Physician 6 - - 4 10 
Physician Trainee - - - - - 
Nurse Trainee - - - - - 
Educator - - - - - 
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Years of experience      
<1 - - 2 - 2 
1-3 2 - 4 - 6 
3-5 - 3 - - 3 
>5 4 6 4 4 18 
Years in current care 
setting 
     
<1 - 1 1 - 2 
1-3 2 2 4 - 8 
3-5 - 2 - - 2 
>5 4 4 5 4 17 
 
4.1.1 Main Findings of Project i 
Research Question 1: What is the perceived understanding of the JVP among primary care 
and LTC clinicians?  
In primary care, two of six physicians assessed JVP by visually observing either the 
internal or external jugular vein. One of the nine primary care nurses, a NP, assessed JVP by 
visual observation of either the external or internal jugular vein and used a dichotomous 
classification of the measure. 
  "So I’ll look at the JVP but I don’t need a number. If it’s bounding, if it’s   
  elevated, I can tell it’s elevated. I look, you can see the earlobe jiggle, and you  
  know you have an elevated JVP." – Primary Care NP 
 In LTC, three of four physicians assessed JVP. All used visual observation and 
dichotomously classified the measure as elevated or not. One participant expressed concern as to 
whether any physicians other than cardiologists use the Lewis method. One of the ten LTC 
nurses who had assessed JVP had done so only on one patient during clinical exposure in nursing 
school. In this instance, the participant used visual observation and dichotomous classification of 
the variable. The other nine nurses stated that they do not measure JVP and had forgotten skills 
involved with the assessment.    
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  “This one was really easy for us, we didn’t have to assess or anything….you can  
  just look and it’s right there (vein distension)” – LTC RN 
  “(RN1) just graduated…..she (RN1) is the only one that knows. The rest of us  
  have all forgot.” – LTC RN 
Overall, twenty three of twenty nine participants stated that they never assessed JVP in 
their respective care settings. Of those who did, visual observation using either the external or 
internal vein seemed to be the technique of assessment.  
Research Question 2: How do clinicians in primary care and LTC perceive the acceptance 
of the Mespere CVP 1000 System to measure JVP? 
 The six primary care physicians would rarely consider using the device on patients in 
their care setting, if at all. 
 “I think it (device use) would be rare, I can think of one patient in the last 
 year…..forty five year old guy that was short of breath and very fatigued. I 
 assumed he had pneumonia, he was actually in congestive heart failure…no MI, 
 no setup….biventricular, severe heart failure. I didn’t look at his JVP, who knows 
 what a JVP is? (Laughter) If we had strapped it (the device) on, because he was 
 short of breath so the nurses would have done it as part of his triage and his JVP 
 was twelve, that would have gotten my attention…..once I looked up what the 
 normal range should have been for JVP.” – Primary Care Physician 
 The physicians stated that they were satisfied with their current strategy of volume status 
assessment to manage HF. One participant highlighted that in the case of new onset or worsening 
HF, the device would not alter the decision to transfer patients to the ED. Overall, primary care 
physicians perceived little need for the device to measure JVP.    
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None of the nine primary care nurses appeared willing to readily accept the device for 
JVP assessment. The numeric device measure was perceived as confirmation of visual 
estimation. On enquiring of the perceived role of the device in primary care, the response was: 
  “I don’t think so – if it’s not going to make any difference to your course of action 
  then I don’t see why it would.” - Primary Care NP 
 NPs also perceived that the care of HF was a role for the ED and thus their acceptance of 
the device was also limited, 
  "Would a number change the disposition of the patient or how I manage them?  
  No…..if he or she has acute heart failure, I’m going to send them into emerg  
  because I don’t know why the patient is in acute heart failure."  
  – Primary Care NP 
  “If I see it clinically that she has a bounding JVP, she is going to emerg   
  regardless of  the number that I get.” –Primary Care NP 
  “When we get someone here with active CHF or having an exacerbation…..it’s 9- 
  1-1….off to the ER.”- Primary Care RPN 
          Acceptance of the device by LTC clinicians was in marked contrast to that of primary care 
clinicians. All 4 LTC physicians indicated that they would like to use the device for the 
assessment of JVP for their patients.  One physician stated that this device would be helpful to 
assess the JVP and that the use of the device would be similar to the use of an oxygen saturation 
meter, that is, correctly positioning the device and recording the value.  
 “What I compare it to is the technology of oxygen saturation which has changed 
 in the past ten years, where I now carry around an oximeter with me that costs 
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 seventy dollars. Having that little piece of information is now something that I just 
 take for granted, it’s like having a blood pressure or a pulse rate, and I just take it 
 for granted that is going to be part of the data set a nurse is going to present to 
 me if she has to call me about a patient. So I can see this device being something 
 that you can just count on." – LTC Physician  
The LTC nurses expressed acceptance for the device and were enthusiastic about its 
potential implementation. They recognized that the device could provide an additional objective 
measure to assist in the care of older adults, 
 “Well, this can become a vital sign. Not for emergency uses or anything like  
  that, but as another vital sign for those of our residents who we’re changing  
  medications for.”- LTC RPN 
  LTC physicians were confident in the nurses' ability to learn how to use the device 
effectively. One participant mentioned that most of the RNs in LTC were senior clinicians who 
understood the complexities of medically caring for older adults. With more objective measures 
available, such as the JVP, care would inevitably improve. As seen in the following quote, it was 
believed that POC investigative testing is best suited for nurses as opposed to physicians,     
   “You know, an RN who gets trained on this is going to be good. RNs are   
  sometimes better than physicians at this kind of thing because they are very rule  
  bound people, in terms of their personality dimensions and their goals. They are  
  usually very empathic, we physicians tend to be more analytical but nurses are  
  very good at doing something that has an algorithm with it.”- LTC Physician 
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 Research Question 3: How do the clinicians in primary care and LTC perceive the ease of 
use of the Mespere CVP 1000 System to measure JVP? 
All the primary care physicians perceived that the device was easy to use, and that its 
guided prompts were appealing. Among the primary care nurses, there were varying views on the 
perceived ease of use of the device. Four of the nine nurses perceived that the device could be 
easily used, though interpretation of the recorded value was not clear. 
  “It’s easy enough to use…..just the interpretation”- Primary Care RPN 
             “It’s user friendly, but it’s more…What do you do with the measure?” 
  – Primary Care NP 
      Five primary care nurses perceived that the device was not easy to use. Nurses seemed to 
find the process of inclining and reclining the patient cumbersome,  
  “On a scale of 1 to 10….5.”- Primary Care RPN 
  “I wouldn’t feel comfortable with the device – doing it myself and verbally telling  
  the doctor what I see. If he’s in the room with me and I do it, that’s fine but I  
  wouldn’t feel  comfortable.” – Primary Care RPN 
All the LTC physicians perceived that the device was easy to use and that after one or 
two in-service sessions, they would feel comfortable operating it in the home. Of the ten LTC 
nurses, all perceived that the device was easy to use. It was pointed out that the features that 
made the device easy to use included the clear labels, simple instructions, appropriate size, and 
the prompts. As highlighted by the nurses, the device was simpler to use than expected,  
 “It tells you what to do, I don’t have to guess.”- LTC RN 
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 Research Question 4: What do clinicians in primary care and LTC perceive as barriers to 
the implementation and use of the Mespere Venous 1000 CVP System?  
Perceived barriers according to primary care physicians 
(i) Patient Centric Factors 
 Primary care physicians perceived patients’ intimidation about medical technology as a 
barrier to the implementation of the device. Furthermore, patients’ mobility in terms of 
positioning themselves onto the examination table was reiterated as a common barrier to using 
the device. Physicians were also concerned about nurses’ ability to accurately locate the 
anatomical landmarks for the device patches. The participants noted that locating these markers 
could be difficult in their HF patients as the majority of them may be older, sometimes obese 
with large mammary glands which can further make location of the 4th intercostal space 
challenging, if using the nipple line.     
(ii) Time Constraints 
 Time was perceived as another barrier. Physicians stated that the target time per patient 
visit of ten minutes could deter use of the device. They further suggested that medical devices 
would have to provide useful information to be worth the extra time. They seem to prefer devices 
that have scanning mechanisms rather than patches used by the Mespere device. 
(iii) Cost 
 Cost was raised as a potential barrier by two of the six participants. The device was 
thought to be expensive.  
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Perceived barriers according to primary care nurses 
(i) Location of the Anatomical Landmarks 
 All primary care nurses perceived as a barrier, the ability to locate the mid axillary line, 
external jugular, and fourth intercostal space, as stated,  
  “this intercostal thing I find very hard….feel like I have probe for it.” 
  - Primary care RPN 
  “So underneath the clavicle, is that the first intercostal?”- Primary care RPN  
  “You can’t feel number four….it’s one, two and then to twelve and use the nipple  
  line….where the nipple should be." – Primary Care NP 
 Fewer nurses had difficulty locating the mid-axillary line compared to the fourth 
intercostal space. This barrier was perceived to be exacerbated when the device has to be used on 
obese patients, who are short of breath or uncomfortable,   
 “again, the placement.... we tried it on a healthy, young person yesterday who is 
 anatomically….it should be easy and  yet, the placement of the thing, we couldn't 
 get it….imagine trying to do it on someone who is obese and not comfortable.”  
 – Primary Care NP 
 (ii) Health System Resources  
 Primary care nurses anticipated that lack of mechanical medical beds would be a barrier 
for implementation of the device. The device prompts require inclining or reclining the patient 
when the patches are on to ensure that the height of the pulse can be detected and having to 
perform this manually on the non-mechanical beds in their clinic would require significant 
strength,      
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  “You really have to push it in and pull it up (referring to bed)….you need   
  muscles.” – Primary Care RPN 
(iii) Time constraints  
          Similar to the primary care physicians, primary care nurses perceived time constraint as a 
barrier for device use and implementation. NPs stated that their standard time allotment for 
patient assessment was between two to three minutes. They stated that incorporation of the 
device may not be feasible without extending patient assessment time. One NP suggested that 
RPNs do the measure on the basis that,    
 “Nurses don’t really have time to do that (use the device)….the RPNs might 
 because they see patients separately but we’ve got to get the patient in the room 
 and out in two or three minutes so unless there is more time allotted, I can’t see 
 the nurses doing it." – Primary Care NP 
       However, one RPN noted that the longer allotted assessment time may still be insufficient to 
acquire the measure. 
 "it might take you 15 minutes to get them up and undressed and do the physical 
 assessment…if we’re going to spend 10 of that doing this, it will eat up  a lot of 
 time.”-Primary Care RPN   
 NPs agreed with the RPNs that undressing and transferring a patient onto the examination 
bed might take up to 10 minutes. It was perceived that this would be especially problematic in 
older, frail patients and the time constraints could be a barrier to using the device to measure 
JVP, as evidenced in the following quote,    
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  “Nobody is going to take that thing into a room to measure JVP…realistically  
  speaking I doubt it…because of timing issue and because you are probably going  
  to rely on other means to diagnose it at a specific time so uh, maybe on some  
  patients in the heart failure clinic it will be useable but if you leave it there,  
  nobody is going to grab it and check the JVP.”- Primary care NP 
Perceived barriers according to LTC physicians 
 (i) Dementia and Resident Co-operation  
 The LTC physicians perceived that the inability of some residents, especially those with 
dementia, to remain still to place the patches could be a barrier for the device use. 
 "A lot of demented residents cooperate if they are apathetic, and a lot of others 
 are agitated so they pull off everything, so it's hard to estimate but it's a big 
 number." – LTC Physician 
 However, a physician pointed out that the device use would only be impeded in specific 
dementia cases, and emphasized the medical importance of identifying and managing HF,    
 “You know for most dementia people, that’s not going to be a huge problem. It 
 might be a problem for people who have frontal temporal or people who have 
 atypical frontal Alzheimer's but you’re going to worry less about that than their 
 heart failure.” – LTC Physician 
 Although estimates of the severity of barrier varied, all four physicians perceived that 
only in a subset of residents, using the device may not be easily possible due to the severe 
agitation and lack of cooperation by residents.   
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(ii) Nurse Accuracy  
 A significant potential barrier noted by all four physicians was concern surrounding the 
nurses’ ability to locate the anatomical landmarks needed to obtain a precise measure,   
  "I would have concerns about whether the nurses are positioning the patients  
  properly, going through the maneuvers and using it appropriately.”  
  – LTC Physician 
 The physicians posited that in older, obese adults with droopy skin, locating the 
phlebostatic axis and external jugular could be even a greater challenge. Skillful use of the 
device also seemed to be a point of apprehension for the physicians as they perceived that the 
nurses may not be using them often enough for adequate practice.  
 (iii) Cost and Size of Device 
 Cost and size of the device were cited as potential barriers to device implementation and 
use. The LTC physicians thought that the price of the device was too high and could be the main 
factor to impede its implementation. One physician who was medical director of a LTC home 
stated:  
 "Cost isn't always a problem. These homes have sort of slush funds for devices so 
 they will have $500 for an  ultrasound so $10,000 is crazy money and you have to 
 get everyone to ok it.....so if you could get the cost down under $1,000, that would 
 be ideal." – LTC Physician 
          One of the four LTC physicians noted that the device was slightly too large and perceived 
that to a lesser extent, size of the device could be a barrier. This view pertained to both the 
docking stand and the handheld component. Participants also pointed out a few additional minor 
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barriers including: adequate availability of consumables, for example, disposable patches; and 
storage procedures for easy accessibility in a timely manner by the nurses.  
Perceived barriers according to LTC nurses  
 (i) Resident Centric Barriers  
 The LTC nurses perceived that dementia and resident cooperation could be barriers to 
device use. Another nurse pointed out that the residents might tug and pull on the neck strap or 
not comply with requests to lie in bed, making an accurate measure impossible to elicit and 
hence a barrier to the device use. 
 “They wouldn’t let us touch them even. We can’t apply the blood pressure 
 apparatus.” – LTC RPN 
 Pulling at patients’ skin when removing the adhesive patches was also seen as a barrier to 
the device implementation. A final barrier perceived was resident’s fear for technological 
devices.  The nurses described that medical technology could intimidate LTC residents as they 
become worried that they are severely ill,   
 “Even checking their vitals, they are asking 'am I fine?' and 'why are you doing 
 this?”– LTC RPN 
 This concern was anticipated to be highly individualized and not prevalent but could 
extend to resident families as well. 
  “It may worry the resident or they might go to bed and not remember the next  
  day, it’s really quite individualized. It might worry the family members for those  
  who do remember.....a resident might say to them 'they hooked me up, I must have 
  been really sick yesterday'. ”- LTC RN 
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 It was believed that this might lead to frantic family members requesting information and 
highlights the importance of the nurses being able to explain why the test was performed and its 
significance. 
(ii) Solutions to Resident Centric Perceived Barriers   
 LTC nurses provided solutions to the resident centric barriers. They stated that residents’ 
cooperation as a barrier also arose during routine assessment of vitals. In such instances, the 
nurses have existing solutions which could also be applied to use of the device,  
 “We just approach several times in order to get the right number and reading.”  
 – LTC RPN      
 In light of this suggestion, other nurses noted that obtaining vitals was sometimes 
impossible by referencing a recent resident who was not cooperative and vitals could not have 
been measured.   
 The participants also suggested a solution to the second barrier surrounding resident skin. 
In the care setting, skin on the neck was believed to be highly elastic, lending towards possibility 
of a tear when removing the adhesive patches. However, the nurses suggested that this barrier 
may be negated with careful and slow removal, 
  “Well if she had skin like (resident), it might not work so well, it did pull a bit. It  
  would  have to be like everything else, just need to be careful.” – LTC RPN     
 Some nurses addressed the concern of residents’ fear by drawing similarities to vital sign 
assessment, stating that the barrier might be overcome once residents become familiar with the 
device as was the case with sphygmomanometers. They also stated that offering the resident 
reassurance would help.  
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(iii) Clinician Factors 
 Nurses perceived difficulty locating the anatomical landmarks. Differentiating the carotid 
artery from the external and internal jugular was initially challenging but once shown how to 
palpate the vein by gently pressing down on the clavicle, identification improved although this 
was an unsystematic observation. Nurses noted difficulty locating the phlebostatic axis. Locating 
the fourth intercostal space was perceived to be more challenging.  
(iv) Cost  
 The LTC nurses perceived cost of the device as a barrier to the device implementation. 
One nurse suggested that a cost benefit analysis of the device could address this barrier.   
4.1.2   Secondary Findings of Project i  
 Analysis of Project i data identified additional findings to those which addressed the 
research questions.  
Primary Care Physicians 
Theme I: Perceived Ability to Diagnose and Manage HF  
 This theme focuses on the management and diagnostic decision making of HF among 
physicians in primary care. It captures aspects of the diagnostic process and can be organized 
into the following subthemes: i) Perceived Diagnostic and Management Confidence; and ii) 
Time Constraints and Availability of Investigative Tests. 
Subtheme (i): Perceived Diagnostic and Management Confidence 
 The physicians expressed a high degree of confidence in their ability to diagnose new 
onset HF. Participants acknowledged that HF was a clinical diagnosis coupled with supporting 
investigative tests in a relatively straightforward process: 
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  “I think it’s [HF] easy to identify…just finding why it is that way and making that 
  conclusion….and start the treatment…it’s not difficult to do.”  
  – Primary Care Physician 
 For acute HF, one participant acknowledged that a large differential exists especially 
when a patient is short of breath but having gone through the physical examination and clinical 
history, they stated that one should be able to narrow it down to HF,  
  “Certainly there are lots of cases where you see someone come in with shortness  
  of breath, your differential is quite large but based on your clinical exam and  
  history…you should be able to narrow it down.” – Primary Care Physician 
 Other physicians noted transferring acute cases of HF to the ED based upon symptoms 
such as shortness of breath. The severity of the condition appeared to dictate management 
disposition and interestingly, lack of confirmatory investigative tests was linked to low 
confidence of management in primary care,   
  "If they are in what you hope is a little bit of failure, maybe you can medically  
  manage them and send them home. If they are in overt failure, they may need to  
  go to emerg because we can’t probably work them up.” 
   – Primary Care Physician 
Subtheme (ii): Diagnostic Time Constraints and Availability of Investigative Tests 
 Despite their expressed high confidence in establishing a HF diagnosis, participants noted 
that time was a significant diagnostic and management barrier,  
 “It just takes some time to assess fully for heart failure because it involves 
 physical examination, history and then some investigation and all these are 
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 needed before the diagnosis at the end…..this is not something you can diagnose 
 within one session.”– Primary Care Physician 
 There was an overall reliance on chest X-rays and echocardiograms to aid in the 
diagnosis of HF and the limited availability of these investigative tests might contribute to the 
diagnosis requiring multiple visits. However, there were additional intermittent factors involved 
including frailty,   
  “So it depends on when we see the patient. We have a x-ray and lab next door so  
  if the patient is not too frail to go over there and do it, then that’s what most of us  
  will do but we wouldn’t get those results back until tomorrow….so it will be  
  helpful but not immediately. Echocardiogram is usually weeks down the road if  
  you want to actually get an anatomical look and get a measurement of ejection  
  fraction….you can’t do that quickly. If it’s after hours in the evening or on the  
  weekend, we don’t have lab or x-ray…………” – Primary Care Physician 
Theme II: Perception and Confidence in Assessing JVP          
 This theme describes knowledge of and perceptions towards the JVP measure among 
primary care physicians. Three subthemes were identified: i) Devaluation of JVP; ii) Skill and 
Confidence in Assessment; and iii) Barriers to Assessment.   
Subtheme (i): Devaluation of the JVP     
 The majority of primary care physicians perceived the JVP as adding little value to the 
clinical picture of the patient in comparison to the other clinical signs. A physician elaborated 
upon this thought, citing a preference for shortness of breath, peripheral edema, and an increase 
in weight. 
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 "I don’t think it would change my management...... if I’ve got a known heart 
 failure patient, I'm looking at shortness of breath, ankles swollen and if their 
 weight has gone up….I’m not going to be measuring to see if JVP is ten or twelve 
 millimeters.” – Primary Care Physician  
 A numeric JVP value was viewed as being unimportant as one participant stated that 
patients are managed clinically rather than according to numbers,  
  “You treat clinically, not necessarily with numbers.” – Primary Care Physician 
Subtheme (ii): Confidence in Assessment   
 Five of the six physicians were not confident in their ability to assess the JVP. For one 
physician, lack of confidence and technique began during medical training and never improved. 
  “I have not checked JVP since residency and that was cause I had to…and even  
  then I  don’t think it was accurate...you make it up.” – Primary Care Physician 
  “So JVP, I’d say I do not check it because I’m not good at it and I don’t think it’s  
  helpful for me but the other things in the exam will be more helpful in my opinion  
  for me for what I’m comfortable doing so I don’t know if other people check JVP  
  but I do not check it.” – Primary Care Physician 
 Another participant stated that unless a trainee was on an internal medicine rotation 
during clerkship, checking JVP would be rarely requested and was of the impression that it was 
not an emphasized skill in medical training. 
Subtheme (iii): Barriers to Assessing JVP  
 The two physicians who attempted to assess JVP were unable to do so mainly because 
frail, older patients could not lift themselves onto the examination table. One participant stated 
that this was a significant proportion of the patients, 
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 “I do try to do JVP on my patients that I know I’m monitoring for failure unless 
 they are so frail that they can’t get up on the table which is many of them."  
 – Primary Care Physician 
 Other factors which impeded regular assessment related to patient body type. The 
physicians said it was difficult to locate the jugular veins on individuals with shorter necks or in 
those who were obese. Long, slimmer physiques were said to lend towards easier identification 
of the internal jugular vein.    
Theme III: Device Potential as a Teaching Tool 
 Despite physicians rarely assessing JVP and the belief that it adds little to the clinical 
picture of the patient, a few group members thought that the device could be used as a teaching 
tool for medical trainees. One participant explained how the device could aid in bedside 
teaching,  
  “I think I would use it if I was going to use it here with students and residents as a 
  teaching tool…..I would use it to say 'Tell me what the JVP is' on your clinical  
  assessment and then double check it with this as a way to teach them how to do it  
  clinically…..a study can look at 'are we teaching our residents how to properly do 
  a JVP? can we back it up with this machine?' and then they can move forward  
  using their eyes.” – Primary Care Physician 
Theme IV: Device Potential in a Primary Care Heart Function Clinic  
 The New Vision Family Health Team offers a heart function clinic with one physician 
who took part in the focus group and one NP. The clinic presents a unique environment as it 
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caters only to cardiac patients including those with HF. This physician was one of two who cited 
trying to measure JVP in clinic. 
 “In the heart function clinic we do try to measure JVP if the patient is able to get 
 on the bed and recline at forty five degrees, but sometimes we can’t do it because 
 you know we have some patients who are never come to the clinic. Others are 
 ninety years old, they come in a wheel chair and we can’t get them on the bed so 
 it’s very valuable but on average, I would say probably fifty percent of cases get 
 their JVP checked.” – Primary Care Physician 
 The physician explained that patients in the heart function clinic were attended to for 
thirty minutes or longer as opposed to ten minutes allocated in standard clinic. The physicians 
revealed that even with more time, infrequent visits and limited mobility prevented the regular 
assessment of JVP in up to 50% of patients. The physicians said they were content with their 
current practices with respect to the JVP.  
Primary Care Nurses 
Theme I: Clinical and Physiologic Knowledge of JVP  
 Knowledge of the clinical and physiologic meaning of JVP appeared to be limited in this 
group, more so than among the LTC nurses.  One NP who did not assess JVP emphasized the 
need to understand the significance of increased and decreased levels. It was also viewed as key 
to look at how this information can be woven into clinical practice and this was seen as more 
imperative than the knowledge surrounding how to use the device,     
  “It’s not more so the device, it’s understanding if you have a JVP that is elevated  
  or decreased. I think that’s the biggest thing, understanding the physiology  
  behind that because you’ll learn the placement of putting on the probes. It’s  
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  actually understanding what’s happening with the JVP, I think that’s the most  
  important thing. To get that number is fantastic, so if it’s a quicker way of   
  actually getting that number, even better but to actually understand it, I think  
  that’s where the training of anybody would be needed. As long as you understand  
  why we are putting the probes on there, why do we  need that number? Why is  
  that useful?” – Primary Care NP  
 In addition to an evident knowledge gap, the NP who cited assessing JVP had an 
underlying belief that the measure would differentiate between right sided and left sided failure.  
LTC Physicians  
Theme I: Diagnosis and Management of HF  
 This theme focuses on the diagnostic decision making for HF among physicians in LTC. 
It captures different aspects of the diagnostic process and was organized into the following 
subthemes: i) Diagnostic Confidence; and ii) Diagnostic and Management Challenges.  
Subtheme (i): Diagnostic Confidence  
 In contrast to physicians in primary care settings, diagnostic confidence of the LTC 
physicians for HF was low. Some participants said that most times, the diagnosis of HF could 
just as likely be another condition and a lot of guesswork was done in identifying the presence of 
the syndrome. In general, LTC participants tried to avoid sending patients to outpatient clinics 
due to lack of mobility which often times required transportation facilitated either by the family 
or an external care provider. They noted that it would be an upsetting experience for residents 
with dementia to leave their familiar surroundings in the LTC home to be sent out for a test. 
Another practical concern was finding someone to accompany the resident to the clinic. These 
factors acted to deter LTC physicians from requesting external investigative tests.   
72 
 
Subtheme (ii): Diagnostic and Management Challenges    
 Evaluating patients for new onset or acute HF was a process fraught with multiple 
barriers in LTC. One barrier to physical examination was resident compliance with instructions 
such as when a physician requests a resident to take a deep breath to listen for chest sounds. 
Also, physicians stated that a thick chest wall would interfere with their ability to hear chest 
sounds and being unable to physically move residents due to frailty or obesity made physical 
examination a cumbersome process.  The physicians admitted that a large differential diagnosis 
with numerous etiologies exists for LTC residents who are short of breath. 
 "You might not think of it (heart failure) immediately unless they have great big 
 swollen feet. There is a big differential for shortness of breath in long term 
 care……it can be anything from heart attack, exacerbation, COPD, pulmonary 
 embolism or  heart failure. So you’re relying a lot on your clinical exam which is 
 sometimes difficult.” – LTC Physician 
 Further compounding the large differential was the potential for the co-existence of 
multiple conditions. One physician described difficulty in determining whether the symptoms 
and signs, peripheral edema for example, stemmed from a lung or cardiac condition and in the 
most some cases, both might be coexisting. Specific examples included an established HF patient 
who had developed pneumonia or vice versa. Referring to diagnostic uncertainty, one participant 
stated that,    
  "The acutely short of breath patient, you don't know, is it pneumonia? or is it  
  heart failure? You know what I do now is treat both, I'll put them on antibiotic  
  and diuretic which is pretty meatball medicine....and then ship them up to emerg  
  if they don't get better. Plus it depends on the family, like some families demand  
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  that they go to the hospital, and others you can say 'let's just try to deal with it at  
  the nursing home' so you have to get a feel for the family." –LTC Physician 
 The barriers to accurately diagnosing HF are more pronounced in those with dementia, 
  "The people I see in long term care, 60 to 80% of them have dementia. Shortness  
  of breath has to be an observed thing once the staff get to know them then they  
  can tell me that and it depends on the skill of the staff person. I’m not going to  
  observe it directly as I only go in the mornings so I’m not there in the late   
  evening. Most of the time staff is absolutely amazing at reporting these things,  
  they are very good and I really do rely on them.” –LTC Physician 
 Nurses’ stress and their workload were concerns expressed by the LTC physicians. One 
participant said that requesting too many resident assessments might result in nurses’ frustration 
and hence a premature transfer to hospital to alleviate the strain. As alluded to previously, 
physicians are very wary of this and stated that because of this feeling, residents’ weights were 
infrequently obtained making it an unreliable measure in the event of acute illness,       
  “They’re all very busy (nurses) so weighing a significant number of people every  
  day is difficult so we don’t do that with most people…..heart failure may come on  
  really  quickly so we might not have a weight that’s really recent or a couple of  
  weights taken  recently…..and if they are acutely ill, can’t weigh them.”  
  –LTC Physician 
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 One participant expressed difficulty in educating families about older adult care and also 
highlighted the many negatives if a physician were to discourage a family from transferring a 
loved one to hospital, 
  "Hospitals are terrible for old people....it's old people unfriendly but it takes a lot  
  of work with families to get over that. For example, yesterday I have a resident  
  who was dying and I said 'we should just keep him comfortable and do nothing'  
  and they family freaks out, it's like 'you're killing my dad'. Well, he's dying,  
  everyone dies and I can say, 'I will be there three times a week, keep a close eye,  
  give you a call' a lot of work on my behalf, it's a lot easier to punt to the ER.  
  And there's no reward for it and tremendous consequences if you get an angry  
  family.....you got 10 years of grief at the college and law suits and the   
  newspaper....so there is tremendous downside, no upside so most doctors and  
  nurses just get rid of them to the hospital, we're trying to educate people to it  
  and it's slow change in thinking but it's really tough." –LTC Physician 
 There was a widespread feeling among the LTC physicians that hospitals were steadily 
offloading a higher proportion of older adults to LTC homes, 
  "We see the hospitals downloading everything on us because the hospitals are so  
  pressed. I just got an email from the hospital saying they are overloaded, I just  
  wrote back to the president of the hospital saying 'I'm really tired of these bed  
  alerts, I get them 365 days of the year, I'm just ignoring them now'....so there is  
  this constant pressure to get everybody out of the hospital, I had a guy yesterday  
  who got sent to the home on intravenous and we do dialysis. So we're becoming a  
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  hospital, traditional hospital are getting less and less beds while nursing homes  
  are getting more but there is that feeling there of dumping on us."  
  –LTC Physician 
 Despite increasing care demands, the physicians observed that there was not a 
proportional increase in resources, namely, staff, medical devices, and tools to better diagnose 
and manage residents in LTC care setting.    
Theme II: Confidence and Barriers to Assessing JVP  
The physicians who assessed JVP were not confident in their ability to obtain an accurate 
measure. As one physician stated, there appears to be a disconnect in physicians' perceived 
ability and actual proficiency in measuring the pressure,    
  "I think it's (JVP) one of those things that's poorly done and everyone thinks they  
  can do  it. It's terrible, they literally can't do it, you do need a machine. It's like  
  trying to estimate your blood pressure by looking at your arm, it's that stupid, like 
  we never guess on blood pressure, never guess on pulse. I mean you have to do  
  the pulse and look at the clock, it is really stupid that we rely on clinical judgment 
  because we measure everything else....it's crazy isn't it?" –LTC Physician 
 The physicians were not confident in their ability to measure JVP but this did not appear 
to deter them from assessing the measure,   
  “I try, I look at it, I make a comment about it but I’m never confident that’s really  
  that’s  going on.” –LTC Physician 
 Contributing factors to this are obese residents with fatty necks which was cited as 
common in LTC. One physician added that obese individuals render the JVP measure useless.  
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 Older adult conditions, such as kyphosis and scoliosis lead to postural issues, making it 
difficult to observe the neck clearly as well as to appropriately position the patient. One 
physician stated that when the JVP was assessed, the resident was rarely, if ever at forty five 
degrees. Being unable to conveniently move residents, and erosion of skill were the greatest 
barriers cited by the one physician who did not incorporate the JVP in diagnostic or management 
decisions,     
 “I guess I’ve gotten out of the habit of it because usually when I’m assessing 
 people, they are sitting either in their wheel chair or they are laying in bed so you 
 get away from finding that forty five degree angle and getting your rulers out is 
 cumbersome.” –LTC Physician 
 One physician expressed the view that minimal assessment of JVP eventually causes this 
maneuver to be abandoned over time.    
LTC Nurses 
Theme I: Clinical and Physiologic Knowledge  
 These participants appeared to be unaware of the clinical significance of an elevated or 
low JVP measure. Nurses expressed interest into which values warranted management from a 
physician,  
 “So what’s the number when we would want to immediately call the doctor?”  
 – LTC RN 
 If the JVP was high, the nurses were aware that resident’s illness could be fluid related. 
Interpretation of the JVP waveform was outside of the nurses’ purview but many participants 
appeared receptive to additional training and educational aids if needed,  
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  “I personally wouldn’t be comfortable reading the waveform – I would be happy  
  with the number but for the waveform, I’m not comfortable reading ECGs either.” 
  – LTC RPN 
 The nurses expressed the need for sufficient knowledge to explain to the resident and 
family, the meaning of the test and measure.      
 Overall, JVP was not assessed by the majority of participants in this study and those who 
did used visual observation and categorical classification. The clinicians in LTC appeared to 
have a higher level of acceptance of the POC device and intended to use it to assess patients 
assigned to their care. The device was perceived as easy to use by the majority of clinicians. 
Barriers common to both settings included cost and ability to accurately locate the anatomical 
landmarks. Time constraints in primary care and patient centric factors such as elastic skin and 
patient cooperation in LTC were outlined as unique barriers. Secondary findings relating to 
clinical knowledge, diagnostic confidence of HF, and perceptions of JVP were also identified.       
4.2 Findings of Project ii  
 Of the 59 residents who were approached to participate in this Project, 36 consented. This 
accounted for a response rate of 61%.  Participant characteristics are shown in TABLE 4.  
TABLE 4 - LONG TERM CARE RESIDENT DIAGNOSES AND MEDICATIONS 
 
 Number of Patients (n=36) 
 
Average Age 83.2 
Sex  
Female 23 (66%) 
Male 13 (33%) 
  
Diagnoses  
Hypertension 26 (72%) 
Arthritis  17 (47%) 
Alzheimer's and Related Dementias 14 (39%) 
Diabetes 13 (36%) 
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Osteoporosis 13 (36%) 
Depression  9 (25%) 
Atherosclerotic heart disease 8 (22%) 
Anemia  8 (22%) 
Heart Failure  6 (17%) 
Chronic Obstructive Pulmonary Disease  6 (17%) 
Hyperlipedemia 5 (14%) 
Macular Degeneration  5 (14%) 
Atrial Fibrillation 4 (11%) 
  
Co-Morbidities   
10 + conditions 8 (22%) 
8 - 9 conditions 7 (19%) 
6 - 7 conditions  7 (19%) 
3 - 5 conditions 13 (36%) 
1- 2 conditions  1 (3%) 
  
Medications  
Pain Reliever  32 (89%) 
Statin  15 (42%) 
Proton Pump Inhibitor  12 (33%) 
Selective Serotonin Reuptake Inhibitor   11 (31%) 
Diuretic  11 (31%) 
ACE Inhibitor  11 (31%) 
Laxative   9 (25%) 
Anti-Diabetic   9 (25%) 
Anti-Diarrhea  8 (22%) 
Calcium Channel Blocker 7 (19%) 
Beta Blocker  7 (19%) 
Anticoagulant  6 (17%) 
Cholinesterase Inhibitor  5 (14%) 
Nitrates 5 (14%) 
Corticosteroid  4 (11%) 
Antihistamine  4 (11%) 
 
Results of the JVP assessments are shown in TABLE 5. 
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TABLE 5 - MEASURES OF JUGULAR VENOUS PRESSURE   
Resident 
ID 
Physician 1 
(cm H2O)  
Physician 2 
(cm H2O) 
Physician 
Difference 
(cm H2O) 
Nurse 1 
(cm H2O) 
Nurse 2 
(cm H2O) 
POC 
Device 
Difference  
(cm H2O) 
001 8  7  1 15  14 1 
002 8  5  3 16  16  0 
003 8  8  0 2 2 0 
004 9  7  2  5 0 5 
005 8  7  1 16 16 0 
006 9  6  3 6 5 1 
007 10  6 4 0 3 3 
008 8.5  5  3.5 5  2 3 
009 8  6  2 5.5  12  6.5 
010 8  5  3  3 11 8 
011 11  6  5 3  10  7 
012 13  7  6 5  10.5  5.5 
013 7  8  1 6.5  0 6.5 
014 12 5 7 5  3.5 1.5 
015 5 8 3 6 7.5 1.5 
016 8  6.5  1.5 2 14 12 
017 9.5  6 3.5 9 11  2 
018 11  6.5  4.5 13 19  6 
019 8   5 3 7 9.5  2.5 
020 8  5 3  5 2 3 
021 7.5  5  2.5 4 4 0 
022 8  6.5  1.5 13 15  2 
023 8.5  5 3.5 10 17  7 
024 10  5 5 2 0 2 
025 7.5  7 0.5 10 10 0 
026 9  5  4  2  1 1.5 
027 9  5  4 7  14.5 7.5 
028 9.5  7.5  2  5 11  6 
029 8  5  3 0 2 2 
030 9  5  4 6  2 4 
031 8  5  3 6.5  3 3.5 
032 9.5  5 4.5 1 2 1 
033 7.5  5.5 2 2  9.5  7.5 
034 8.5  8  0.5 7  8  1 
035 10  9.5 0.5 11 11.5  0.5 
036 8  5 3 1.5  2  0.5 
 
Mean 
 
8.74 
 
6.08 
 
2.875 
 
6.19 
 
7.79 
 
3.361 
 
80 
 
TABLE 6 shows that the inter-rater reliability of nurse assessments using the device was 
greater than that of the physicians.  
TABLE 6 - INTRACLASS CORRELATION COEFFICIENTS  
 ICC2 (A,1)  (95% CI) 
Nurses 0.63 (0.38 - 0.79) 
Physicians - 0.02 (-0.34 - 0.31) 
 
 The interaction plots for the nurses and physicians can be found in FIGURES 7 and 8  
respectively as shown below. 
FIGURE 7 - INTERACTION PLOT FOR NURSE MEASURES  
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FIGURE 8 - INTERACTION PLOT FOR PHYSICIAN MEASURES   
 
 
 
  
 
 
 
 
 
 
 
 
 
The plot lines found in the interaction plots above do not intersect at any point. Thus, one 
rater in both groups consistently under or overrated the JVP of the residents.    
As previously outlined, some clinicians expressed a preference for a categorical 
classification of JVP. The normal interval for JVP is from 4 to 8 cm H2O (Socransky et al., 2010) 
and from this, the interval created for low, medium and high levels are 0 < to ≤ 3, 4 ≤ to ≤ 8 
and ≥ 9 respectively. In this case, the reliability of the variable by physicians and nurses can also 
be analyzed using the level of agreement and a weighted kappa as shown is TABLE 7 and 8 
respectively. 
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TABLE 7 - INTERRATER AGREEMENT FOR CATEGORICAL CLASSIFICATION  
 Nurse 1 
 
 
Nurse 2 
 Low Normal High 
Low 7 7 0 
Normal 0 4 0 
High 4 5 9 
 
 Physician 1 
 
 
Physician 2 
 Low Normal High 
Low 0  0  0 
Normal 0 18 17 
High 0 0 1 
 
TABLE 8 - WEIGHTED KAPPA 
 Weighted Kappa (95% CI) 
 
Nurses 0.3903 (0.1956 - 0.5850) 
Physicians  0.1104 (-0.0934 - 0.3143)  
 
 The findings reveal that inter-rater reliability of the numeric scale between the nurses was 
fair to good (TABLE 6). Conversely, the reliability between the physicians’ measures was poor. 
The point estimate for ICC2 (A,1) was significantly different from 0 for the nurses but not for the 
physicians. For the collapsed, categorical scale, the nurse weighted kappa was 0.3903 (TABLE 
8) which reflects fair to moderate agreement between measures while 0.1104 indicates very poor 
agreement (Altman, 1991).   
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CHAPTER 5 
 
DISCUSSION AND CONCLUSION 
 
             The overall aim of this study was to conduct a preliminary evaluation of the feasibility 
and acceptability of using the Mespere Venous 1000 CVP System to measure JVP for the 
diagnosis and management of HF in primary care and LTC. 
5.1 Discussion  
 
 The findings indicate that the acceptability, and perceived ease of use of the device were 
greater among the LTC clinicians than among the primary care clinicians. A number of reasons 
were identified.  
 Care processes in primary care appear to be still geared towards more expeditious 
disposition of patients with suspected HF, especially to the ED even though the transfers are 
sometimes unnecessary (Grumbach, Keane & Bindman, 1993). In primary care, care processes 
may be redesigned to facilitate management of complex conditions such as HF, in which case, 
the device might be seen eventually as more acceptable. In contrast, in LTC, where transfers of 
residents to the ED are seen less favorably, acceptability of the device is greater. The findings 
corroborate previous literature which has shown that LTC clinicians prefer to avoid sending 
residents to the ED (Heckman et. al, 2014). The differing views may be attributed to the 
awareness among LTC clinicians of the detrimental effects of unnecessary hospitalizations for 
older adults (Bail et al., 2015).  The findings suggest that the Mespere Venous 1000 CVP System 
is perceived as an additional useful “vital sign” to help guide diagnostic decision-making in 
LTC.  
Physicians in both settings expressed a concern as to whether nurses can use the device to 
reliably measure JVP. The results of Project ii indicate that the nurses’ measurements were more 
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reliable than that of the physicians using the Lewis method, despite still being modest. Studies 
investigating inter-rater reliability of the JVP have used categorization of the measure. Findings 
using two different methods of ultrasonography to identify JVP found kappa values of 1.0 and 
0.87 (Socransky et al., 2010), conferring substantially higher reliability than the weighted kappa 
obtained with the Mespere 1000 CVP System. Dichotomously identifying neck vein distension 
during physical examination has been shown to confer fair to good reliability at 0.71 (Maestre et 
al., 2009). Importantly, none of these studies was explicit in how variable categories were 
determined or measured. The need for clearer descriptions of how the JVP was measured in 
research studies reporting the variable has been acknowledged (Sankoff & Zidulka, 2008). These 
studies were conducted in ICU units and EDs on younger patients who were acutely ill. The 
likelihood of true positive cases of HF is greater in these settings than in the convenience sample 
of LTC residents who participated in this investigation. Therefore, the measurement of JVP in 
previous studies may have been easier due to the increased pressure and easily observable vein 
distension among acutely sick individuals, potentially inflating the reliability reported in those 
studies.      
 It has been recommended that for clinical practise, reliability of a measure should 
approach 0.95 (Streiner & Norman, 2009). This value was chosen arbitrarily and a value of 0.95 
indicates that 95% of the variability is due to true variability while 5% is attributed to 
measurement error. Streiner & Norman specify that due to clinical measures leading to treatment 
options and diagnoses, a stringent cut-off is needed. However, the recommendation does not 
invalidate the findings of this investigation. Clinically, assessment of JVP is used in conjunction 
with other components of physical examination, history and investigative tests to diagnose and 
manage HF. Thus, the reference by Streiner and Norman may not hold true with regards to the 
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necessary reliability for the device measure. A convenient sample of residents who were 
otherwise stable was used for this investigation. In the event of suspected acute HF, it is likely 
that more residents would have elevated JVPs and thus reliability may be higher. The reliability 
in a sample of acutely ill residents would need to be demonstrated. The training protocol and 
practice session necessitate review to further investigate whether reliability can be improved. 
This was the first study to estimate the reliability of physician raters using numeric values 
obtained by the Lewis method in an older adult population, thereby, limiting the ability to 
compare to other reliability coefficients.     
 The findings reveal that additional perceived barriers in primary care appear to be related 
to the availability of equipment. Time constraints can be compounded by the difficulty in 
accessing mechanical examination tables but this may be specific to the primary care setting used 
in the study. These barriers were not perceived to be an issue in LTC. The nurses in LTC offered 
solutions to the patient centric barriers which included added care with the application of 
patches, and attempting to assess a patient multiple times because of agitation or uncooperative 
behavior which can sometimes be  due to dementia. It should be noted that, although the 
prevalence of dementia in LTC is approximately 30% (Yu et al., 2012), it remains unclear how 
many of these residents would have behavioral concerns severe enough to impede the use of the 
device. To this end, the proposed solutions by the LTC nurses indicate their willingness to adopt 
the device, therein confirming acceptability. 
 Cost of the device was a concern for clinicians in primary and LTC settings. Currently, 
the equipment is priced at $10,000 but as is customary with new technology, it is expected to 
decrease over time. Considering that CIHI’s patient cost calculator estimates that the average 
cost of a HF hospitalization without a coronary angiogram is $7,411 (CIHI, 2013), it can be 
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speculated that avoidance of a small number of hospitalizations may offset the cost of the device. 
However, this would need to be demonstrated in a large scale efficacy study.  
 The JVP measure was assessed by clinicians using visual observation in both settings 
with results interpreted categorically, rather than using absolute numbers. The findings showed 
that some RNs and NPs learnt of the measure during their formal education but in a non-clinical 
setting. Physicians cited that their experience with the maneuver was limited to internal medicine 
rotations during their clerkship years. For both settings, it seems as if the teaching provided 
during formal education may not fully translate to trainees and practice.  The underutilization 
and varied skill to measure JVP potentially results from a theory-to-practice gap which has been 
a long-standing concern to nursing and medical educators, practitioners, and students (Hewison 
& Wildman, 1996 ; Bjørk, 1995). Qualified nurses have cited feeling unprepared for practice and 
often lacked confidence in their clinical abilities. Poor confidence has been linked to inadequate 
time dedicated to the refinement of clinical skills during training (Monaghan, 2015). Despite the 
progressively higher levels of formal education among participants, clinical skill and confidence 
surrounding the JVP did not seem to improve.     
There was a difference in the perceptions of the LTC physicians and primary care 
clinicians towards the role of JVP in HF diagnosis and management. Primary care physicians 
expressed greater confidence in diagnosis than the LTC physicians and downplayed the 
importance of the JVP. Primary care physicians were also confident that their chronic HF 
patients were managed well due in part to a high degree of patient self-care. Previous studies 
have suggested that physical examination (Cook, 2010; Salcido, 2012) and especially the JVP 
are devalued (Garg & Garg, 2000) but none have attempted to quantify or describe the value of 
the JVP in primary care. The low diagnostic confidence of the clinicians in LTC is consistent 
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with existing literature (Hancock et al., 2014). The high confidence of the primary care 
physicians in this study may be attributed to their belief of appropriate practice despite relying on 
the ED. The appropriateness of transfers to and reliance on the ED by primary care clinicians 
remains unexplored. Nonetheless, a large number of ED cases relating to acute HF have been 
found to be avoidable as these patients are often not severely ill but instead have congestion due 
to worsening chronic HF, and require only symptomatic treatment (Collins et al., 2013). HF 
patients needing hospital based services not available in primary care, such as intravenous 
inotropic agents, mechanical circulatory support, hemodynamic monitoring, invasive diagnostic 
testing or intense therapeutic regimens account for a minority of admissions (Abraham et al., 
2005; Adams et al., 2005 ; Gheorghiade et al., 2011). Other studies have confirmed that many 
patients who arrive in the ED were not in need of an acute intervention beyond decongestion 
(Fonarow et al., 2008 ; Weintraub et al., 2010). Avoidance of the ED is possible with the caveat 
that patients receive timely and effective care in the community (Collins et al., 2013). 
Furthermore, any follow-up by the family physician for a patient transferred to the ED would be 
hinged upon the opinion of another physician, potentially complicating the management of the 
patient.      
Essentially, LTC physicians are also family physicians and would have therefore 
undergone similar formal training. Despite their lower confidence in diagnosing HF, the LTC 
physicians in this study were more experienced than the primary care clinicians. The discrepancy 
in experience suggests that the primary care physicians may be overconfident in their abilities. A 
study of general practitioners in the UK found that diagnostic overconfidence was independent 
of diagnostic accuracy and case difficulty, potentially preventing physicians from reconsidering 
treatment and disposition options for their patients (Meyer, Payne, Meeks, Rao & Singh, 2013). 
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This notion could hold true for the sample of primary care clinicians in this study. 
Notwithstanding, they dismissed JVP which specialists have stated is useful in diagnosis.  
 The high diagnostic confidence found in primary care may be biased as the clinic 
involved in the study had an adjoining HF program. Although the assessment of clinical skill 
knowledge was not an objective of this study, secondary findings were consistent with a 
knowledge gap surrounding the clinical significance of the measure.   
5.2 Strengths and Limitations 
 Acceptability, perceived ease of use of the device, and barriers to its implementation 
were evaluated through the perceptions of clinicians in primary care and LTC. Assessing 
perceptions from both care settings contributed in validating the findings. The findings provide 
an opportunity for additional research to be conducted to address potential barriers and/or 
facilitators for implementing the device in LTC where it was found to be more acceptable. 
Furthermore, this was the first study to investigate perceptions and reliability of a JVP measuring 
device in primary care and LTC. The use of qualitative and quantitative data in this study is 
unique in that it allowed for the interpretation of perceptions towards the device while providing 
insight into the reliability of the measure.  
          There were a few limitations to the study. The focus groups in primary care and LTC were 
conducted at single sites. This could have biased the results and affected the ability to generalize 
findings to other clinical settings. A kappa statistic was not calculated for the thematic analysis 
of qualitative results. Due to a restriction on time and resources, a second coder confirmed the 
initial codes as opposed to independently coding the transcripts. This may bias the themes that 
emerged and disproportionately influenced the qualitative findings. For Project ii, excluding 
residents with a CPS score of greater than or equal to 2 introduces selection bias into the sample 
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and limits the ability to generalize the reliability findings to a broader spectrum of LTC residents. 
However, ethical obligations were contingent upon a resident having sufficient cognitive ability 
to provide informed consent in order to participate in the study. Not all residents with a CPS 
score of greater than 2 would have been unexaminable.  
 The physicians’ measures for the quantitative component were taken within a 48 hour 
interval. The stability of the JVP measure has not been formally investigated but given its many 
determinants, the variable could have inherently changed over this time frame. This would have 
produced unaccounted variation and could have skewed the results. However, despite this 
interval, most residents were stable and it would have been unusual for a large proportion to have 
had adjustments to diuretic dosage.    
5.3 Recommendations  
 Based on the findings of this study, four recommendations are suggested. Some stem 
from an individual project while others are data triangulated and are based on both components 
of the investigation.  
           With reference to the JVP measure, the following are suggested:  
(i)  Provide clinicians with resources to make them aware of the importance of JVP 
      to diagnose and manage HF; 
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  Recommendations relating to the Mespere Venous 1000 CVP System include:  
 (ii) Determine how to improve device reliability, potentially through a more rigorous  
        training module;   
 (iii)  Conduct a cost-effective analysis for usage of the Mespere CVP 1000 System in    
          primary care and LTC settings; and 
 (iv) Explore alternate uses of the device, namely as a teaching tool. 
5.4 Conclusion 
 Many clinicians did not appreciate the importance of the JVP and if they did, were not 
comfortable with its assessment. The most popular method of assessment was visual observation 
which can lead towards considerable variability and subjectivity surrounding the measure. The 
Mespere Venous 1000 CVP System was perceived as more acceptable in LTC and provided 
numerous benefits as recognized by the clinicians. Furthermore, the measures obtained by the 
device provided a more reliable measure of JVP than the Lewis method in LTC. Thus, the 
potential of the device to improve diagnostic accuracy and reduce hospitalization through better 
management warrants further investigation. In primary care settings, enhanced care processes for 
diagnosis and management of HF may lead to acceptance of the device.   
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APPENDIX ii 
 
Minnesota Living with Heart Failure Questionnaire 
Did your heart failure prevent you from living as you wanted 
during the last month by: 
1. causing swelling in your ankles, legs, etc.? 
2. making you sit or lie down to rest during the day? 
3. making your walking about or climbing stairs difficult? 
4. making your working around the house or yard difficult? 
5. making your going places away from home difficult? 
6. making your sleep at night difficult? 
7. making your relating to or doing things with your friends and family difficult? 
8. making your working to earn a living difficult? 
9. making your recreational pastimes, sports, or hobbies difficult? 
10. making your sexual activities difficult? 
11. making you eat less of the foods you like? 
12. making you short of breath? 
13. making you tired, fatigued, or low on energy? 
14. making you stay in a hospital? 
15. costing you money for medical care? 
16. giving you side effects from medicine? 
17. making you feel you are a burden to your family or friends? 
18. making you feel a loss of self-control in your life? 
19. making you worry? 
20. making it difficult for you to concentrate or remember things? 
21. making you feel depressed? 
Source: (Rector and Cohn, 1992) 
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APPENDIX iii 
 
PRIDE clinical scoring system for Acute Heart Failure  
Predictor Odds Ratio  Score 
Age (>75 years old) 2.7 (95% CI 1.4 - 5.2) 1 
Lack of cough   2.3 (95% CI 1.2 – 4.3) 1 
Current loop diuretic (before 
presentation) 
3.4 (95% CI 1.8 – 6.4) 1 
Rales on lung exam 2.4 (95% CI 1.2 – 4.7) 1 
Orthopnea present  9.6 (95% CI 4.0 – 23.0) 2 
Lack of fever 6.0 (95% CI 2.0 - 18.0) 2 
Interstitial edema on chest x-ray 11 (95% CI 4.5 – 26.0) 2 
Elevated NT-proBNP (≥ 450 pg/mL 
if age ≤ 50 years and ≥ 900 pg/mL 
if age ≤ 50 years ) 
44 (95% CI 21.0 - 91.0) 4 
Source: (Baggish et al., 2006) 
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APPENDIX iv 
 
CCS Algorithm for diagnosis of Chronic Heart Failure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Source: (McKelvie et al., 2012) 
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APPENDIX v 
 
Device Protocol  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
111 
 
APPENDIX vi 
Consent Form 
By signing this consent form, you are not waiving your legal rights or releasing the 
investigator(s) or involved institution(s) from their legal and professional responsibilities.  
______________________________________________________________________ 
I have read the information presented in the information letter about the session being facilitated 
by Vishaka Chetram for Dr. George Heckman, Associate Professor, School of Public Health and 
Health Systems and Dr. Veronique Boscart, Adjunct Professor. I have had the opportunity to ask 
the facilitator any questions related to this session, to receive satisfactory answers to my 
questions, and any additional details I wanted. I am aware that I may withdraw from the session 
without penalty at any time by advising the facilitator of this decision.  In appreciation of my 
time given to this session I am aware that I will receive a $5 gift certificate. 
This project has been reviewed by, and received ethics clearance through a University of 
Waterloo Research Ethics Committee.  I understand that if I have any comments or concerns 
resulting from my participation in this study, I may contact the Director, Dr. Maureen Nummelin 
in the Office of Research Ethics at 1-519-888-4567, Ext. 36005 or 
maureen.nummelin@uwaterloo.ca 
This study has also been reviewed and received ethics clearance through the Conestoga College 
(CCITAL) Research Ethics Board.   
If you have questions regarding your rights as a research participant, contact: 
Research Ethics Coordinator 
Conestoga College Institute of Technology and Advanced Learning  
299 Doon Valley Drive, Kitchener, ON, N2G 4M4 
rebcoordinator@conestogac.on.ca 
With full knowledge of all foregoing, I agree, of my own free will, to participate in this session 
and to keep in confidence information that could identify specific participants and/or the 
information they provided. 
 
 
Print Name 
 
 
Signature  
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Recruitment Letter  
**Note: this letter will be distributed by administrators to recruit potential participants on behalf 
of the researchers** 
Hello staff members/students,  
 The following letter is being distributed on behalf of the researchers at the University of 
Waterloo.  
 My name is Vishaka Chetram and I am a graduate student in the School of Public Health 
and Health Systems at the University of Waterloo. I am currently conducting a research project 
for my Master’s thesis under the supervision of Dr. George Heckman. Dr. Veronique Boscart is a 
co-investigator for the project and is a Schlegel Research chair at the University of Waterloo and 
a faculty member with Conestoga College.  
  I am seeking nurses/physicians/trainees to conduct a usability analysis on a point of care 
device to measure jugular venous pressure and its’ utility in diagnosing Heart Failure in your 
care setting. You will be asked to observe a demonstration of the device, have a brief trial period 
and then participate in a guided focus group designed to assess usability, perceived barriers and 
feasibility. The session will take approximately 2 hours. For your participation in the study, 
lunch will be provided and you will receive a $5 Tim Horton’s gift card. I want to reassure you 
that this study has been reviewed by and received ethic clearance through a University of 
Waterloo Research Ethics Committee and the Conestoga College Research Ethics Board.  
 If you are interested in participating, please contact me at vkchetram@uwaterloo.ca with 
your expressed interest. I will provide you with further information about the study and let you 
know the  location and time of the focus group. I am open to answering any questions you may 
have. Please note that your choice to participate is entirely voluntary and I understand if you are 
not interested or your schedule does not fit these sessions.  
 
Thank you.  
 
Vishaka Chetram  
School of Public Health and Health Systems | University of Waterloo   
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APPENDIX vii 
Focus Group Guide  
 
Completed by RA: ____________________________  
Other:_____________________________ 
Date:____________________________________ 
Faculty – LTC Staff  - Group #________________ 
Focus groups (n=2 staff groups and n=2 faculty groups)  
Week 1 
 
Introduction 
Thank you for participating in the study. We appreciate your comments and thoughts in relation 
to the study.  
1. Start with overview of study and objectives of focus groups 
2. Explain consent and audio tape procedures  
3. Start audio tape (state date and focus group number) 
 
Focus Group Questions 
Measuring the height of the jugular vein is a useful way to determine whether a person might 
have heart failure. If the jugular vein is elevated, this suggests that the resident has an elevated 
central venous pressure and might be retaining fluid, as might occur in heart failure. If it is low, 
this suggests that the resident might be dehydrated. Mespere Life Sciences has developed a 
portable device that helps measure central venous pressure in the external jugular vein. This 
device could be useful to assess patients with suspected heart failure in primary care and LTC 
settings by nurses in these settings. 
 
I would like to discuss some of your beliefs and perspectives to better understand your view on 
the device. In this focus group, we will discuss your thoughts on the use of a device as an 
assessment tool to assess residents/patients for possible heart failure.  
 
Note: There may be variations and omissions in the questions depending on the progress of the 
study and the responses from the participants.  
 
Perceptions of Device 
 
1. What problems have you encountered that you feel are barriers for assessing 
suspected heart failure in long term care/primary care? 
 
2. What role do nurses play in assessing long term care/primary care residents/patients 
with suspected HF?  
 
a. How comfortable are you in your ability to assess a resident/patient with 
suspected heart failure? 
i. How well do you understand jugular venous pressure measurement? 
ii. Do you assess the jugular vein on a regular basis? What challenges do 
you face in doing so? 
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b. How comfortable are you informing a colleague or a physician about a 
resident/patient you suspect might have heart failure? 
 
3. Do you think that the Venus 1000 might have a role in assessing LTC residents/ 
primary care patients with suspected HF? 
a. How comfortable do you feel in using the device? 
b. If the device were to be adopted for use in the LTC/primary care setting for 
this purpose, what barriers might be encountered? When? Where? How? How 
often? With whom? 
c. How would the information obtained from the device be used in care 
planning? 
d. What processes could be put in place to guide and support this process? 
e. How long do you think new implementation of this device in your care setting 
would take? 
 
4. Do you foresee any positive or negative outcomes of this device on resident/patient 
outcomes? Staff or facility/practice outcomes? Do you foresee these 
outcomes/consequences as long-term or short term? 
 
5. In what other ways might this device help nurses improve care to older adults? 
 
6. Do the benefits of the device outweigh the costs (about $8000.00) associated with it? 
 
Closing Focus Group 
 
I would like to thank you for your input and perspectives. Are there any other comments you 
would like to make or stories you would like to share? 
 
Thank you. 
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APPENDIX viii 
 
Feedback Letter 
 
Hello,  
  
 Thank you for participating in our study. Your insight has been incredibly valuable and 
very much appreciated by our research team. The purpose of our study is to conduct an 
acceptability, perceived barriers and usability assessment of the Venus 1000 CVP System for 
two applications: 
 
1..Use of the device as an assessment tool to measure the JVP of patients in primary care 
and LTC settings by registered nursing staff in these settings;  
 
 2..Use of the device as a teaching tool to detect and measure the JVP to help train nursing 
 students and family medicine residents. 
 
 As a reminder, all information collected during this study, will be kept confidential and 
will not be shared with anyone outside the study unless required by law. You will not be named 
in any reports, publications or presentations that may come from this study. We will not make 
public anything that might identify you or your family, unless legally required to do so. Your 
name will be removed and replaced with a coded number to protect your identity. Only the 
research staff at the University of Waterloo will have access focus group transcripts and data. A 
summary of the results of the study will be provided to the sponsor, Mespere Life Sciences.  
 If you have any questions, concerns or would like to speak to the study team for any 
reason, please contact Vishaka Chetram, BSc, Research Assistant at (519) 781-7864 and/or 
vkchetram@uwaterloo.ca . The anticipated completion date of the research report is October 31st, 
2014 and you may request a copy by contacting Vishaka Chetram.   
 If you have any questions about your rights as a research participant or have concerns 
about this study, you may, as always, contact Dr. Maureen Nummelin, the Director, Office of 
Research Ethics, at 1-519-888-4567, Ext. 36005 or maureen.nummelin@uwaterloo.ca or the 
Research Ethics Coordinator at Conestoga College Institute of Technology and Advanced 
Learning,(CCITAL) by email at rebcoordinator@conestogac.on.ca. This project was reviewed 
by, and received ethics clearance through a University of Waterloo Research Ethics Committee 
and the Conestoga College Research Ethics Board.   
 
Thank you.  
 
 
 
Vishaka Chetram  
School of Public Health and Health Systems | University of Waterloo  
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APPENDIX ix 
 
ICC Macro  
 
%macro intracc(data=_LAST_,target=TARGET???,rater=RATER???, 
               depvar=DEPVAR???,nrater=0,out=_DATA_,print=1); 
 
title2 'Intraclass Correlations for Inter-Rater Reliability'; 
proc glm data=&data outstat=_stats_ 
  %if &print<3 %then noprint; ; 
  * use glm to get sums of squares for use in reliability calculation; 
  class &target &rater; 
  model &depvar = &target &rater ; 
  run; 
 
proc sort data=_stats_; 
  by _name_ _SOURCE_; 
  run; 
 
%if &print>=2 %then %do; 
proc print data=_stats_; 
  title3 'Statistics from 2-way ANOVA w/o Interaction'; 
  run; 
%end; 
 
data &out; 
  title3 'Calculate all reliabilities in one fell swoop'; 
  retain msw msb wms ems edf bms bdf jms jdf k; 
  set _stats_; 
  by _name_; 
  if upcase(_type_)='SS1' then delete; 
  if upcase(_source_)='ERROR' then do; 
     ems=ss/df; 
     edf=df; 
  end; 
  if upcase(_source_)="%upcase(&target)" then do; 
     bms=ss/df; 
     msb=bms; 
     bdf=df; 
  end; 
  if upcase(_source_)="%upcase(&rater)" then do; 
     jms=ss/df; 
     jdf=df; 
     k=df+1; 
  end; 
  if last._name_ then do; 
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    msw=((ems*edf)+(jms*jdf))/(edf+jdf); 
    wms=msw; 
    n=bdf+1; 
    theta=(msb-msw)/(k*msw);                   * used in Winer formulae; 
    wsingle=theta/(1+theta);                   * Winer ICC(1,1); 
    wk=(k*theta)/(1+k*theta);                  * Winer ICC(1,k); 
    %if &nrater %then %do; 
    wnrater=(&nrater*theta)/(1+&nrater*theta); * Winer reliability 
                                                 if mean of nraters; 
    %end; 
    sfsingle=(bms-wms)/(bms+(k-1)*wms);        * ICC(1,1); 
    sfrandom=(bms-ems)/ 
        ((bms)+((k-1)*ems)+((k*(jms-ems))/n)); * ICC(2,1); 
    sffixed=(bms-ems)/(bms+((k-1)*ems));       * ICC(3,1); 
    sfk=(bms-wms)/bms;                         * ICC(1,k); 
    sfrandk=(bms-ems)/(bms+((jms-ems)/n));     * ICC(2,k); 
    sffixedk=(bms-ems)/bms;                    * ICC(3,k) with no 
                                                 interaction assumption; 
    output; 
  end; 
  label wsingle="Winer reliability: single score" 
        wk="Winer reliability: mean of k scores" 
        %if &nrater %then %do; 
        wnrater="Winer reliability: mean of &nrater scores" 
        %end; 
        sfsingle="Shrout-Fleiss reliability: single score" 
        sfrandom="Shrout-Fleiss reliability: random set" 
        sffixed="Shrout-Fleiss reliability: fixed set" 
        sfk="Shrout-Fleiss reliability: mean k scores" 
        sfrandk="Shrout-Fleiss rel: rand set mean k scrs" 
        sffixedk="Shrout-Fleiss rel: fxd set mean k scrs"; 
run; 
 
%if &print %then %do; 
proc print label; 
  id _name_; 
  var msw msb wms ems edf bms bdf jms jdf k theta 
      wsingle wk %if &nrater %then wnrater; 
      sfsingle sfrandom sffixed sfk sfrandk sffixedk; 
run; 
%end; 
 
%mend intracc; 
 
 
 
 
